Use: Labeled indications
- INDICATIONS AND USAGE Before instituting treatment with Ceftriaxone for Injection, USP, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the…
Full indications and usage US FDA label
INDICATIONS AND USAGE Before instituting treatment with Ceftriaxone for Injection, USP, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ceftriaxone for Injection, USP and other antibacterial drugs, Ceftriaxone for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Ceftriaxone for Injection, USP is indicated for the treatment of the following infections when caused by susceptible organisms: LOWER RESPIRATORY TRACT INFECTIONS caused by Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Escherichia coli, Enterobacter aerogenes, Proteus mirabilis or Serratia marcescens.
ACUTE BACTERIAL OTITIS MEDIA caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta‑lactamase producing strains) or Moraxella catarrhalis (including beta-lactamase producing strains). NOTE: In one study lower clinical cure rates were observed with a single dose of Ceftriaxone for Injection, USP compared to 10 days of oral therapy.
In a second study comparable cure rates were observed between single dose of Ceftriaxone for Injection, USP and the comparator. The potentially lower clinical cure rate of Ceftriaxone for Injection, USP should be balanced against the potential advantages of parenteral therapy (see CLINICAL STUDIES). SKIN AND SKIN STRUCTURE INFECTIONS caused by Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Viridans group streptococci, Escherichia coli, Enterobacter cloacae, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, Morganella morganii 1, Pseudomonas aeruginosa, Serratia marcescens, Acinetobacter calcoaceticus, Bacteroides fragilis 1 or Peptostreptococcus species.
URINARY TRACT INFECTIONS (complicated and uncomplicated) caused by Escherichia coli, Proteus mirabilis, Proteus vulgaris, Morganella morganii or Klebsiella pneumoniae. UNCOMPLICATED GONORRHEA (cervical/urethral and rectal) caused by Neisseria gonorrhoeae, including both penicillinase- and nonpenicillinase-producing strains, and pharyngeal gonorrhea caused by nonpenicillinase‑producing strains of Neisseria gonorrhoeae.
PELVIC INFLAMMATORY DISEASE caused by Neisseria gonorrhoeae. Ceftriaxone for Injection, USP, like other cephalosporins, has no activity against Chlamydia trachomatis. Therefore, when cephalosporins are used in the treatment of patients with pelvic inflammatory disease and Chlamydia trachomatis is one of the suspected pathogens, appropriate antichlamydial coverage should be added.
BACTERIAL SEPTICEMIA caused by Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae or Klebsiella pneumoniae. BONE AND JOINT INFECTIONS caused by Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Proteus mirabilis, Klebsiella pneumoniae or Enterobacter species. INTRA-ABDOMINAL INFECTIONS caused by Escherichia coli, Klebsiella pneumoniae, Bacteroides fragilis, Clostridium species (Note: most strains of Clostridium difficile are resistant) or Peptostreptococcus species.
MENINGITIS caused by Haemophilus influenzae, Neisseria meningitidis or Streptococcus pneumoniae. Ceftriaxone for Injection, USP has also been used successfully in a limited number of cases of meningitis and shunt infection caused by Staphylococcus epidermidis 1 and Escherichia coli. 1 1 Efficacy for this organism in this organ system was studied in fewer than ten infections.
SURGICAL PROPHYLAXIS The preoperative administration of a single 1 gm dose of Ceftriaxone for Injection, USP may reduce the incidence of postoperative infections in patients undergoing surgical procedures classified as contaminated or potentially contaminated (e.g., vaginal or abdominal hysterectomy or cholecystectomy for chronic calculous cholecystitis in high-risk patients, such as those over 70 years of age, with acute cholecystitis not requiring therapeutic antimicrobials, obstructive jaundice or common duct bile stones) and in surgical patients for whom infection at the operative site would present serious risk (e.g., during coronary artery bypass surgery). Although Ceftriaxone for Injection, USP has been shown to have been as effective as cefazolin in the prevention of infection following coronary artery bypass surgery, no placebo-controlled trials have been conducted to evaluate any cephalosporin antibiotic in the prevention of infection following coronary artery bypass surgery.
When administered prior to surgical procedures for which it is indicated, a single 1 gm dose of Ceftriaxone for Injection, USP provides protection from most infections due to susceptible organisms throughout the course of the procedure.
Contraindications
- Hypersensitivity to ceftriaxone or other cephalosporins
- Premature neonates up to 41 weeks postmenstrual age; hyperbilirubinemic neonates
- Neonates (28 days or younger) needing calcium-containing IV solutions
Contraindications (US label) US FDA label
CONTRAINDICATIONS Hypersensitivity Ceftriaxone is contraindicated in patients with known hypersensitivity to ceftriaxone, any of its excipients or to any other cephalosporin. Patients with previous hypersensitivity reactions to penicillin and other beta lactam antibacterial agents may be at greater risk of hypersensitivity to ceftriaxone (see WARNINGS – Hypersensitivity).
Neonates Premature neonates: Ceftriaxone is contraindicated in premature neonates up to a postmenstrual age of 41 weeks (gestational age + chronological age). Hyperbilirubinemic neonates: Hyperbilirubinemic neonates should not be treated with ceftriaxone. Ceftriaxone can displace bilirubin from its binding to serum albumin, leading to a risk of bilirubin encephalopathy in these patients.
Neonates Requiring Calcium Containing IV Solutions Ceftriaxone is contraindicated in neonates (≤ 28 days) if they require (or are expected to require) treatment with calcium‑containing IV solutions, including continuous calcium-containing infusions such as parenteral nutrition because of the risk of precipitation of ceftriaxone‑calcium (see CLINICAL PHARMACOLOGY, WARNINGS and DOSAGE AND ADMINISTRATION). Cases of fatal outcomes in which a crystalline material was observed in the lungs and kidneys at autopsy have been reported in neonates receiving ceftriaxone and calcium-containing fluids.
In some of these cases, the same intravenous infusion line was used for both ceftriaxone and calcium-containing fluids and in some a precipitate was observed in the intravenous infusion line. There have been no similar reports in patients other than neonates. Lidocaine Intravenous administration of ceftriaxone solutions containing lidocaine is contraindicated.
When lidocaine solution is used as a solvent with ceftriaxone for intramuscular injection, exclude all contraindications to lidocaine. Refer to the prescribing information of lidocaine.
Dosing: Adult
- Usual adult dose: 1 to 2 g IV or IM once daily (or divided twice daily); maximum 4 g/day
- Uncomplicated gonococcal infection (label): 250 mg IM once
- Surgical prophylaxis: 1 g IV once, 30 minutes to 2 hours before surgery
- Kidney impairment: No change up to 2 g/day (label)
Dosage and administration (US label) US FDA label
DOSAGE AND ADMINISTRATION Ceftriaxone may be administered intravenously or intramuscularly. Do not use diluents containing calcium, such as Ringer’s solution or Hartmann’s solution, to reconstitute ceftriaxone vials or to further dilute a reconstituted vial for IV administration because a precipitate can form. Precipitation of ceftriaxone-calcium can also occur when ceftriaxone is mixed with calcium-containing solutions in the same IV administration line.
Ceftriaxone must not be administered simultaneously with calcium‑containing IV solutions, including continuous calcium-containing infusions such as parenteral nutrition via a Y-site. However, in patients other than neonates, ceftriaxone and calcium-containing solutions may be administered sequentially of one another if the infusion lines are thoroughly flushed between infusions with a compatible fluid (see WARNINGS).
There have been no reports of an interaction between ceftriaxone and oral calcium-containing products or interaction between intramuscular ceftriaxone and calcium-containing products (IV or oral). NEONATES Hyperbilirubinemic neonates, especially prematures, should not be treated with ceftriaxone. Ceftriaxone is contraindicated in premature neonates (see CONTRAINDICATIONS).
Ceftriaxone is contraindicated in neonates (≤28 days) if they require (or are expected to require) treatment with calcium‑containing IV solutions, including continuous calcium‑containing infusions such as parenteral nutrition because of the risk of precipitation of ceftriaxone-calcium (see CONTRAINDICATIONS). Intravenous doses should be given over 60 minutes in neonates to reduce the risk of bilirubin encephalopathy.
PEDIATRIC PATIENTS For the treatment of skin and skin structure infections, the recommended total daily dose is 50 to 75 mg/kg given once a day (or in equally divided doses twice a day). The total daily dose should not exceed 2 grams. For the treatment of acute bacterial otitis media, a single intramuscular dose of 50 mg/kg (not to exceed 1 gram) is recommended (see INDICATIONS AND USAGE).
For the treatment of serious miscellaneous infections other than meningitis, the recommended total daily dose is 50 to 75 mg/kg, given in divided doses every 12 hours. The total daily dose should not exceed 2 grams. In the treatment of meningitis, it is recommended that the initial therapeutic dose be 100 mg/kg (not to exceed 4 grams).
Thereafter, a total daily dose of 100 mg/kg/day (not to exceed 4 grams daily) is recommended. The daily dose may be administered once a day (or in equally divided doses every 12 hours). The usual duration of therapy is 7 to 14 days. ADULTS The usual adult daily dose is 1 to 2 grams given once a day (or in equally divided doses twice a day) depending on the type and severity of infection.
The total daily dose should not exceed 4 grams. If Chlamydia trachomatis is a suspected pathogen, appropriate antichlamydial coverage should be added, because ceftriaxone sodium has no activity against this organism. For the treatment of uncomplicated gonococcal infections, a single intramuscular dose of 250 mg is recommended.
For preoperative use (surgical prophylaxis), a single dose of 1 gram administered intravenously 1/2 to 2 hours before surgery is recommended. Generally, ceftriaxone therapy should be continued for at least 2 days after the signs and symptoms of infection have disappeared. The usual duration of therapy is 4 to 14 days; in complicated infections, longer therapy may be required.
When treating infections caused by Streptococcus pyogenes, therapy should be continued for at least 10 days. No dosage adjustment is necessary for patients with impairment of renal or hepatic function (see PRECAUTIONS). The dosages recommended for adults require no modification in elderly patients, up to 2 gm per day, provided there is no severe renal and hepatic impairment (see PRECAUTIONS).
DIRECTIONS FOR USE Intramuscular Administration: Reconstitute ceftriaxone powder with the appropriate diluent (see COMPATIBILITY AND STABILITY). Inject diluent into vial, shake vial thoroughly to form solution. Withdraw entire contents of vial into syringe to equal total labeled dose. After reconstitution, each 1 mL of solution contains approximately 250 mg or 350 mg equivalent of ceftriaxone according to the amount of diluent indicated below.
If required, more dilute solutions could be utilized. As with all intramuscular preparations, ceftriaxone should be injected well within the body of a relatively large muscle; aspiration helps to avoid unintentional injection into a blood vessel. Vial Dosage Size Amount of Diluent to be Added 250 mg/mL 350 mg/mL 250 mg 0.9 mL — 500 mg 1.8 mL 1 mL 1 gm 3.6 mL 2.1 mL 2 gm 7.2 mL 4.2 mL Intravenous Administration: Ceftriaxone should be administered intravenously by infusion over a period of 30 minutes, except in neonates where administration over 60 minutes is recommended to reduce the risk of bilirubin encephalopathy.
Concentrations between 10 mg/mL and 40 mg/mL are recommended; however, lower concentrations may be used if desired. Reconstitute vials with an appropriate IV diluent (see COMPATIBILITY AND STABILITY). Vial Dosage Size Amount of Diluent to be Added 250 mg 2.4 mL 500 mg 4.8 mL 1 gm 9.6 mL 2 gm 19.2 mL After reconstitution, each 1 mL of solution contains approximately 100 mg equivalent of ceftriaxone.
Withdraw entire contents and dilute to the desired concentration with the appropriate IV diluent.
Dosing: Altered kidney function
Ceftriaxone is cleared by both the kidneys (33% to 67% unchanged) and bile, so its kinetics change little with kidney impairment. The US label needs no dose change up to 2 g per day in kidney impairment, and hemodialysis does not remove it. Encephalopathy, seizures and nonconvulsive status epilepticus have been reported in severe kidney impairment, and in a few dialysis patients elimination was markedly reduced.
Kidney function measure: Label PK table uses CrCl (mL/min); no dose bands.
Show full dosing details
- CrCl ≥60 mL/min
- No dose change (label).
- CrCl 30–59 mL/min
- No dose change up to 2 g per day (label).
- CrCl 15–29 mL/min
- No dose change up to 2 g per day (label).
- CrCl <15 mL/min (not on dialysis)
- No dose change up to 2 g per day, but neurologic adverse reactions (encephalopathy, seizures, myoclonus, nonconvulsive status epilepticus) have been reported in severe kidney impairment; the label asks for appropriate dose adjustment there without giving one. Caution with both severe kidney and liver disease (label).
- Hemodialysis (intermittent)
- No supplemental dose: not removed to any significant extent by hemodialysis (label). Dose up to 2 g per day; elimination was markedly reduced in 6 of 26 dialysis patients in the label's PK data, so watch for neurologic toxicity.
- Peritoneal dialysis
- Not reduced by peritoneal dialysis (label). For PD-associated peritonitis (ISPD 2022): intraperitoneal intermittent 1,000 mg daily; no data for continuous dosing.
- CRRT
- Not in label. Li 2020 (Table 3): no change in CVVH, CVVHD or CVVHDF; clearance on CVVH was similar to normal kidney function.
- Dialyzable? No: not removed to any significant extent by hemodialysis or peritoneal dialysis (label). Protein binding 85% to 95%.
- Monitoring Neurologic status in severe kidney impairment; gallbladder sludge or stones and kidney precipitation (symptomatic ceftriaxone-calcium precipitates); hemolytic anemia; prothrombin time in patients at risk (label).
Children (kidney dosing)
Show full dosing details
- eGFR ≥60
- No pediatric kidney dosing in label; adult label needs no change up to 2 g/day.
- eGFR 30–59
- No pediatric kidney dosing in label; adult label needs no change up to 2 g/day.
- eGFR 15–29
- No pediatric kidney dosing in label; adult label needs no change up to 2 g/day.
- eGFR <15 (not on dialysis)
- No pediatric kidney dosing in label; adult label needs no change up to 2 g/day, but neurologic adverse reactions (encephalopathy, seizures, myoclonus, nonconvulsive status epilepticus) have been reported in severe kidney impairment (label).
- Hemodialysis (intermittent)
- No pediatric dialysis data. Specialist input.
- Peritoneal dialysis
- No pediatric dialysis data. Specialist input.
- CRRT
- No pediatric CRRT data in the cited sources. Specialist input.
Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.
renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.
US label text: Renal impairment US FDA label
Renal Impairment Hemodialysis Patients (0 - 5 mL/min)* 14.7 0.65
Dosing: Pediatric
- Approved ages
- Children, including neonates, except premature neonates up to 41 weeks postmenstrual age, hyperbilirubinemic neonates, and neonates needing IV calcium (label).
- Usual dose
- Serious infections other than meningitis: 50 to 75 mg/kg/day once daily or divided every 12 hours (maximum 2 g/day). Meningitis: 100 mg/kg/day (maximum 4 g/day). Acute otitis media: 50 mg/kg IM once (maximum 1 g) (label).
- Maximum dose
- 2 g/day (4 g/day for meningitis) (label).
Kidney dosing in children: see Dosing: Altered kidney function.
renalcarematters.com, reviewedPediatric use (US label) US FDA label
Pediatric Use Safety and effectiveness of ceftriaxone in neonates, infants and pediatric patients have been established for the dosages described in the DOSAGE AND ADMINISTRATION section. In vitro studies have shown that ceftriaxone, like some other cephalosporins, can displace bilirubin from serum albumin. Ceftriaxone should not be administered to hyperbilirubinemic neonates, especially prematures (see CONTRAINDICATIONS).
Dosage forms
Philippines
- Powder for injection: 1 g, 1 g per vial, 1 g/vial, 2 g, 250 mg, 500 mg
- Powder for inejction: 1 g
- Powder for solution for injection: 1 g
- Sterile powder for injection: 1 g
- Sterile powder for solution for injection: 1 g
- Powder for injection (i.m/i.v: 1 g
- Powder for injection im/iv: 1 g
- Powder for solution for injection / infusion: 500 mg
- Powder for solution for injection /infusion: 1 g
- Powder for solution injection: 1 g
Registered products in the Philippines
399 products registered with the Food and Drug Administration (FDA) Philippines list Ceftriaxone as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: Cefriaxone (as sodium) (1 product) · Ceftriaxone (as sodium (2 products). Products registered under these spellings are included in the table and marked.
All registered products399
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
3-Gen 1000Ceftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories Ltd.India | Speed Cure PharmaImporter: Ambica International Corporation | DRP-4474-15 | Jun 13, 2028 | |
AarexoneCeftriaxone (as Sodium) | 1 g Powder For Injection (IM/IV)10mL-capacity USP Type I clear glass vial with grey butyl rubber stopper and aluminum white flip-off seal (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Aarex Pharma DistributorTrader: AdvaCare International Limited | DRP-12590 | Sep 12, 2027 | |
AccexoneCeftriaxone (As Sodium) | 1 g Powder For Injection (IM/IV)15 mL USP Type I Transparent Plain Glass vial (Box of 1's) | Rx | Medisure Laboratories Pakistan Pvt LtdPakistan | Accesspoint International Trading Inc.Importer: Accesspoint International Trading, Inc. | DRP-11568 | Mar 30, 2027 | |
AccexoneCeftriaxone (As Sodium) | 2g Powder For Injection (IM/IV)USP Type I transparent glass vial with grey butyl rubber stopper and aluminum seal with blue PP flip-off cap (Box of 1's) | Rx | Medisure Laboratories Pakistan (Pvt.) Ltd.Pakistan | Accesspoint International Trading Inc.Importer: Accesspoint International Trading, Inc. | DRP-12657 | Sep 19, 2027 | |
AcrexonCeftriaxone (as Sodium) | 1 g Powder for Injection(IM/IV)Type I Glass Colorless Borosilicate Vial With Flip-off Cap (Box of 10’s) | Rx | Shin Poong Pharmaceutical Co., Ltd.Republic of Korea | Importer: Phil. Shinpoong Pharma Inc. | DRP-290 | Apr 11, 2031 | |
Aetricef-WCeftriaxone (As Sodium) | 1 g Powder For Injection (IM/IV)10 mL-Capacity USP Type III Clear Glass Vial With Grey Rubber Stopper and Blue Flip-Off Seal and Transparent LDPE Plastic Ampoule X 10 mL (Diluent) Box of 1's and Box of 1 vial + Ampoule Diluent | Rx | Inject Care Parenterals Pvt. Ltd.India | Dynasty PharmaceuticalsImporter: Aglobal Care, Inc.Trader: Antila Lifesciences Pvt. Ltd. | DRP-8832-02 | Nov 19, 2031 | |
AfactoneCeftriaxone (as sodium) | 1 g Powder For Injection (IM/IV)10 mL-capacity USP type III clear glass vial with rubber stopper and aluminum green flip-off seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Afree Pharmaceutical Distribution Corp. | DRP-14007 | Jun 5, 2028 | |
AirefixCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Jalmed Pharma, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-03 | Nov 20, 2028 | |
AlixoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | HLM Pharmaceutical Inc.Importer: Greencore Pharma Inc. | DRP-10246-11 | Feb 4, 2032 | |
AmbicephCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial (Box of 1's) | Rx | Gnana Life Sciences Pvt. Ltd.India | Pharmalife DistributionImporter: Ambica International Corporation | DRP-4186 | Jan 28, 2028 | |
AmcefriCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type I Glass Vial with Green Colored Flip-off Seal + 10 mL Water for Injection in USP Type I Clear Colorless Glass Ampoule (Box of 1's) | Rx | Zhuhai Kinhoo Pharmaceutical Co., Ltd.China | Amson PharmaceuticalsImporter: Sahar International Trading Inc. | DRP-5929-03 | Sep 30, 2028 | |
AmkoxoneCeftriaxone (As Sodium) | 1g/vial Powder For Injection (I.M./I.V.)Type I Glass Vial W/ Rubber Stopper & Green Flip Off Aluminum Seal + Type I Glass Ampoule X 10ml Diluent (Sterile Water For Injection) (Box of 1's) | Rx | Shanxi Shuguang Pharmaceutical Co., Ltd.China | AMK Pharma International TradingImporter: Asianmeds, Inc. | DRP-2060-02 | Jul 16, 2027 | |
AmplacefCeftriaxone (as sodium) | 1 g Sterile Powder for Injection (IM/IV)10 mL USP Type III glass vial sealed with 20 mm grey bromobutyl rubber stopper with ring and 20 mm dark orange aluminum flip-off seal (Box of 1’s) | Rx | Inject Care Parenterals Pvt. Ltd.India | Suhitas Pharmaceuticals Inc. | DRP-8214 | May 31, 2029 | |
AmtrixCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually boxed USP Type I Borosilicate Glass Vial with Blue Flip-Off Seal (Box of 10's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | AMB HK ENTERPRISES INC. | DRP-3601 | Feb 14, 2029 | |
AntriaxoneCeftriaxone (As Sodium) | 1 g Powder for Injection (IM/IV)10 mL-Capacity USP Type III Clear Glass Vial With Grey Rubber Stopper and Blue Flip-Off Seal (Box of 1's) and Transparent LDPE Plastic Ampoule X 10 mL (Diluent) (Box of 1 vial + Ampoule Diluent) | Rx | Inject Care Parenterals Pvt. Ltd.India | Jackson Pharmaceuticals Inc.Importer: Aglobal Care, Inc.Trader: Antila Lifesciences Pvt. Ltd | DRP-8832 | Nov 10, 2030 | |
ArvexoneCeftriaxone (as Sodium) | 1g/vial Powder for Injection (IM/IV)Type I Glass Vial w/ Rubber Stopper & Green Flip Off Aluminum Seal + 10mL Diluent (Sterile Water for Injection) in Type I glass ampoule (Box of 1's) | Rx | Shanxi Shuguang Pharmaceutical Co., Ltd.China | Health Alliance Pharma, Inc.Importer: Asianmeds, Inc. | DRP-2060-01 | Jul 16, 2027 | |
AxefenCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)USP Type II clear glass vial x 10 mL (Box of 1's and 10's) | Rx | Haikou Pharmaceutical Factory Co. Ltd.China | Endure Medical Inc. | DR-XY44720 | Jul 28, 2030 | |
AxefenCeftriaxone (as Sodium) | 1g Powder for Injection (IM/IV)USP Type II Clear glass vial x 10 mL (Box of 1's and 10's) | Rx | Haikou Pharmaceutical Factory Co. LtdChina | Endure Medical Inc. | DRP-16849 | Jul 28, 2030 | |
AxoneduCeftriaxone (as sodium) | 500 mg Powder for Injection (IM/IV)Antibacterial (Third-generation Cephalosporin) | Rx | Chengdu Brilliant Pharmaceutical Co., Ltd.China | Aglobal Care, Inc. | DRP-15187 | May 22, 2029 | |
AxonefreeCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP Type III clear glass vial with rubber stopper and aluminum green flip-off seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Bliss Pharma Distribution and Consultancy Corp.Importer: Afree Pharmaceutical Distribution Corp. | DRP-14007-01 | Jun 5, 2028 | |
AxonexCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile water for injection as solvent) [Box of 1's] | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | D'Conner PharmaImporter: Sanimed Pharmaceuticals Inc. | DRP-7138-15 | Mar 31, 2027 | |
1g Powder for Injection IM/IVEach box contains: 1 USP Type 1 Clear, Transparent Class Vial with pink flip-off seal (active drug) and 1 10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Ellebasy Medicale TradingImporter: Pharmakon Biotec Inc. | DRP-5240-03 | Apr 7, 2029 | ||
BactriasCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10mL Labeled Flint USP Type III Glass Vial sealed with Grey Butyl Rubber Plug and Grey Color Flip-off Seal (Box of 1's) | Rx | Wockhardt LimitedIndia | Prodrom Nutritionals, IncorporatedImporter: Ambica International Corporation | DRP-846 | Nov 13, 2030 | |
BactricefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL Type II Glass Vial Sealed with Gray Butyl Rubber Stopper and Blue Flip-Off Seal Cap x 1's + 10 mL Colorless and Transparent Type I Glass Ampoule (Sterile Water for Injection: diluent) (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Zakir & Zaheer Paragon Trading, Inc | DR-XY48886 | Sep 15, 2028 | |
BaczoneCeftriaxone (as sodium) | 1g Powder for Injection (IM/IV)10 mL-capacity soda lime glass vial with halogenated butyl rubber stopper and aluminum flip-off seal (Box of 10's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | GPC Geo Pharma Corporation | DRP-12523 | Aug 26, 2027 | |
BeraxoneCeftriaxone (as sodium) | 1g Powder for Injection (I.V./I.M.)10 mL-Capacity USP Type III Flint Glass Vial with Grey Butyl Rubber Stopper and Red Aluminum Flip-Off Seal (Box of 1's) | Rx | Yeluri Formulations Pvt Ltd.India | Beracah Pharma Phils., IncImporter: Medinova Pharmaceutical Inc. | DRP-10960-05 | Dec 22, 2026 | |
BesticareCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M/I.V.Box of 1 - Soda lime glass vial with halogenated rubber stopper and aluminum-plastic flip-off seal + USP Type I Glass Ampoule x 10 mL Water for Injection (Diluent) | Rx | Furen Pharmaceutical Group Co., LtdChina | Euro-Care Products Philippines | DRP-10961 | Dec 22, 2026 | |
BettrixCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type III Colorless Glass Vial (1) + 10 mL Ampoule (Sterile Water for Injection) (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1140-02 | Nov 9, 2031 | |
BiotrixCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue-flip-off seal + 10 mL plastic ampoule (Sterile water for injection as solvent) (Box of 1's) | Rx | Zeiss Pharmaceuticals, Pvt. Ltd.India | Stratmed PharmaImporter: Sanimed Pharmaceuticals Inc. | DRP-7138-06 | Mar 31, 2027 | |
BluecorecefCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Box of 1 - Soda lime glass vial with halogenated rubber stopper and aluminum-plastic flip-off seal + USP Type I Glass Ampoule x 10 mL Water for Injection (Diluent) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Bluecore Philippines Inc.Importer: Euro-Care Products Philippines | DRP-10961-04 | Dec 22, 2026 | |
BluecozoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile water for injection as solvent) (Box of 1's and 10's) | Rx | Zeiss pharmaceuticals Pvt. Ltd.India | Bluecore Philippines Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7138-16 | Mar 31, 2027 | |
C-FixonCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type I Glass Vial (Box of 10's | Rx | Kyung Dong Pharm. Co., Ltd.Republic of Korea | Jazmark PharmaceuticalImporter: H & B Pharma International Inc. | DRP-5834-06 | Sep 12, 2028 | |
CabcefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Cabcare PharmaImporter: Greencore Pharma Inc. | DRP-10246-10 | Feb 8, 2032 | |
CatarinCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)USP Type III Clear Glass Vial with Green Colored Flip-off Seal (Box of 1's and 10's without diluent) | Rx | SYNCOM FORMULATIONS (INDIA) LTD.India | ARVINCARE PHARMA INC. | DRP-1084 | Jun 8, 2028 | |
Cef-3Ceftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Clear and colorless glass vial with orange flip-off seal (Box of 1's) | Rx | PT. Dankos FarmaIndonesia | Lakeside Pharmaceuticals Phil., Inc. | DRP-443 | Oct 7, 2029 | |
CefahilCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL-Capacity USP Type II Glass Vial with butyl rubber stopper and flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-12797-01 | Oct 7, 2027 | |
CefbestCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type II glass mould vials sealed with gray bromobutyl rubber stopper and blue aluminum plastic cap x 10 mL + clear and transparent USP Type I glass ampoule x 10 mL (net content) Sterile Water for Injection as solvent. (Box of 1's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | Best ClearImporter: Medinova Pharmaceutical Inc. | DRP-13685-05 | Mar 28, 2028 | |
CefbronCeftriaxone (as Sodium) | 1g Powder for Injection(IM/IV)Type I Glass Colorless Borosilicate Vial With Flip-off Cap (Box of 10’s) | Rx | Shin Poong Pharmaceutical Co., Ltd.Republic of Korea | Maxipharm Co., Ltd.Importer: PHIL. SHINPOONG PHARMA INC. | DRP-290-01 | Feb 12, 2032 | |
CefftryCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt. Ltd.India | Lourbon Trading, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-02 | Nov 20, 2028 | |
CefisanCeftriaxone (As Sodium) | 1 g Powder for Injection (I.M/I.V.)10 mL-Capacity USP Type II Glass Vial with butyl rubber stopper and flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Sanimed Pharmaceuticals Inc. | DRP-12797 | Oct 7, 2027 | |
CefitraxCeftriaxone (as sodium) | 1g Powder For Injection (I.M./I.V.)10 mL-capacity USP Type II clear and colorless glass vial sealed with grey bromobutyl rubber stopper and aluminum seal with blue plastic flip-off cap 10 mL Sterile Water for Injection in USP Type I clear and colorless glass ampoule (Box of 1's) | Rx | Reyoung Pharmaceutical Co., LtdChina | GPC Geo Pharma Corporation | DRP-13950 | May 24, 2028 | |
CefkerCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP type III clear glass vial with rubber stopper and orange flip-off seal and LDPE plastic ampoule x 10 mL for sterile water for injection (diluent) in a plastic tray (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Health Care Pharma And Medical Supplies DistributionImporter: GPC Geo Pharma Corporation | DRP-15190-01 | May 23, 2029 | |
CefkizonCeftriaxone (as sodium) | 500 mg Powder for Injection (I.M./I.V.)USP Type I Colorless Glass Vial (Box of 10’s) | Rx | Samjin Pharmaceutical Co., Ltd.Republic of Korea | Unimex, Inc. | DR-XY43697 | Sep 3, 2027 | |
CeflorynCeftriaxone Sodium | 1 g Powder For Injection (IM/IV)10 mL-capacity Type II Clear Glass Tubular Vial Sealed with Gray Bromo Butyl Rubber Stopper and Aluminum Seal with Blue Flip-Off Plastic Cap (Box of 1's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | PhilRx Pharma Inc. | DRP-18101 | May 5, 2031 | |
CefloveCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP Type II glass vial with rubber stopper and aluminum blue plastic cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | One That Love TradingImporter: Pharmaessence Inc. | DRP-16426-03 | Mar 10, 2030 | |
CefontCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL Type III glass vial with grey bromobutyl rubber stopper, aluminum seal and blue plastic flip-off cap + 10 mL LDPE ampoule SWFI (diluent) in plastic tray (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Labmate Pharma Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-14065-03 | Jun 13, 2028 | |
CefontCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile Water for Injection as solvent) [Box of 1's] | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Labmate Pharma Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7138-12 | Mar 31, 2027 | |
CeforeCeftriaxone (As Sodium) | 1g Powder For Injection (IM/IV)USP Type I clear glass vial with red flip-off seal and gray butyl rubber stopper + 10mL diluent (Box of 1's) | Rx | PHIL INTER PHARMA CO., LTD. (PLANT 2)Vietnam | ALTOMED PHARMACEUTICALS, INCImporter: LARGEN MED INC | DRP-5461 | Aug 28, 2029 | |
CefravaczCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP Type II Clear Glass Vial Sealed with Gray Bromo Butyl Rubber Stopper and Aluminum seal with Blue Plastic Cap x 1's (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Ambicare Pharmaceuticals Inc. | DRP-17932 | Apr 13, 2031 | |
CefravaczCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP Type II Clear Glass Vial sealed with Gray Bromo Butyl Rubber Stopper and Aluminum Seal with Blue Plastic Cap x 1's + 10 mL Sterile Water for Injection in Type I Glass Ampoule as Diluent (in a box) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Ambicare Pharmaceuticals Inc.. | DRP-17933 | Apr 13, 2031 | |
CefribusinCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection Box of 1's | Rx | Brawn Laboratories Ltd.India | Terramedic, Inc.Importer: Ambica International Corporation | DRP-4474-09 | Jun 13, 2028 | |
CefrimedCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type III Colorless Glass Vial (1) + 10 ml Ampoule (Sterile Water for Injection) Box of 1's | Rx | Inject Care Parenterals Pvt. Ltd.India | Medicamenta Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1140-09 | Dec 8, 2031 | |
CefriwindCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL-capacity USP Type I clear colourless glass vial, with grey bromo butyl rubber plug and sealed with dark pink coloured filp off aluminum seal + Sterile Water for Injection in Clear Glass Ampoule x 10 mL (Box of 1's) | Rx | Kilitch Drugs (India) Ltd.India | Pharmastar Int'l Trading CorpImporter: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-12306-01 | Jul 12, 2027 | |
CeftabonCeftriaxone (as sodium) | 1 g Powder For Injection (I.M./I.V)USP Type I clear glass vial x 10 mL (net content) with bromobutyl rubber stopper and aluminum flip-off seal + USP Type I clear glass ampule x 10 mL (net content) (Sterile Water for Injection) (Box of 1 finished product and 1 diluent) | Rx | GMH OrganicsIndia | Finstad Inc.Trader: Morcel Biotech Pvt. Ltd. | DRP-18202 | Jul 29, 2031 | |
CeftibetCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-4191 | Jan 31, 2028 | |
CeftiBrillCeftriaxone (as sodium) | 1 g Powder For Injection10 mL USP Type III clear and colourless glass vial with grey bromo butyl rubber stopper and aluminium flip off seal + 10 mL translucent plastic ampoule (Sterile water for injection) (Box of 1 's) | Rx | Swiss Parenterals Ltd.India | RCBrilliant Pharma and Medical Supplies TradingImporter: AGlobal Care, Inc. | DRP-16534-03 | May 28, 2030 | |
CeftinorthCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type 1 Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) (Box of 1 Vial & 1 Diluent) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Meganorth PharmaImporter: Pharmakon Biotec Inc. | DRP-5240-19 | Apr 7, 2029 | |
CeftirosCeftriaxone (As Sodium) | 1 g Powder For Injection (IM/IV)10 mL Type III glass vial with grey bromobutyl rubber stopper, aluminum seal and blue plastic flip-off cap + 10 mL LDPE ampoule SWFI (diluent) in plastic tray (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Sanimed Pharmaceuticals Inc.. | DRP-14065 | Jun 13, 2028 | |
Ceftisaph-1000Ceftriaxone (As Sodium) | 1g Powder For Injection (IM/IV)10 mL-capacity USP Type I Clear Glass Vial with grey bromobutyl rubber stopper and aluminum flip-off seal (Box 10's) | Rx | Bueno Salud Care (India) Pvt. Ltd.China | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-13111 | Dec 2, 2027 | |
Ceftisaph-500Ceftriaxone (As Sodium) | 500 mg Powder For Injection (IM/IV)10 mL-capacity USP Type I Clear Glass Vial with grey bromobutyl rubber stopper and aluminum flip-off seal (Box of 1's and 10's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-13011 | Nov 17, 2027 | |
CeftraconCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Box of 1 - Soda lime glass vial with halogenated rubber stopper and aluminum-plastic flip-off seal + USP Type I Glass Ampoule x 10 mL Water for Injection (Diluent) | Rx | Furen Pharmaceutical Group Co., Ltd.China | D'Conner PharmaImporter: Euro-Care Products Philippines | DRP-10961-09 | Dec 22, 2026 | |
CeftragCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Each box contains: 1 USP Type I Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type I Clear, Transparent Ampoule (diluent: Sterile Water for Injection) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Medko Pharmaceuticals DistributorImporter: Pharmakon Biotec Inc. | DRP-5240-30 | Apr 7, 2029 | |
Ceftrash-1000Ceftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL-capacity USP Type III clear and colorless glass vial with grey bromobutyl rubber stopper and aluminum seal with dark pink polypropylene flip-off cap (Box of 1's) | Rx | Shamshree Lifesciences Ltd.India | Khriz Pharma Trading, Inc.Trader: Lob International | DR-XY49031 | Apr 1, 2029 | |
Ceftrash-500Ceftriaxone (as sodium) | 500 mg Powder for Injection (IM/IV)7.5 mL capacity USP Type III clear glass vials with rubber stopper and with scarlet red aluminum flip-off seal (Box of 1's) | Rx | Shamshree Lifesciences Ltd.India | Khriz Pharma Trading Inc. | DR-XY49159 | Aug 5, 2029 | |
CeftratechCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Each box contains: 1 USP Type I Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type I Clear, Transparent Ampoule (diluent: Sterile Water for Injection) (Box of 1 Vial & 1 Diluent) | Rx | Scott-Edil Advance Research Laboratories & Education Ltd.India | One Technodrug Life Sciences Inc.Importer: Pharmakon Biotec Inc. | DRP-5240-26 | Apr 7, 2029 | |
CeftravicCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Flint Glass Vial packed in individual box (Box of 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Grovic Pharma Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-5951 | Jan 23, 2030 | |
CeftravinCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL -capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Vintel Med EnterprisesImporter: Greencore Pharma Inc. | DRP-10246-08 | Feb 8, 2032 | |
CeftrazenCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type I Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type I Clear, Transparent Ampoule (diluent: Sterile Water for Injection) (Box of 1 vial & 1 diluent) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Northmed Pharma and Medical Supplies DistributionImporter: Pharmakon Biotec Inc. | DRP-5240-28 | Apr 7, 2029 | |
CeftreniumCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-Capacity USP Type III Clear Glass Vial with Grey Rubber Stopper and Blue Flip-Off Seal and Transparent LDPE Plastic Ampoule x 10 mL (Diluent) Box of 1's, Box of 10's and Box of 1 Vial + Ampoule Diluent | Rx | Inject Care Parenterals Pvt. Ltd.India | Bernest TradingImporter: Aglobal Care, Inc.Trader: Antila Lifesciences Pvt. Ltd. | DRP-8832-04 | Nov 10, 2030 | |
CEFTREXCEFTRIAXONE (AS SODIUM) | 1 g POWDER FOR INJECTION (I.M./I.V.) | Rx | UNITED BIOTECH PVT. LIMITED | DELEX PHARMA INTERNATIONAL, INC. | DRP-10469 | Mar 19, 2027 | |
CeftriabbasCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Clear Colorless USP Type II Glass Vial with Rubber Stopper and Blue Plastic Protective Cap (Box of 10's) | Rx | FRIENDS PHARMA (PVT.) LTD.Pakistan | RAQUEL-ABBAS PHARMACEUTICALS & GENERAL MERCHANDISE | DRP-10012 | Nov 28, 2028 | |
CeftriaceCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)USP Type I clear glass vial with gray chlorobutyl rubber and blue aluminum cap (Box of 1 's and 10's) | Rx | Kyongbo Pharmaceutical Co., Ltd.Republic of Korea | QLap Endoscopics Inc.Importer: GPC Geo Pharma CorporationTrader: Daewon Pharm. Co. Ltd. | DRP-7533-02 | Dec 1, 2027 | |
CeftriacircCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Each box contains: 1 USP Type 1 Clear, Transparent Glass Vial with Pink Flip-off Seal (Active Drug) and 1-10 mL USP Type 1 Clear, Transparent Ampoule (Diluent: Sterile Water for Injection) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | PharmaCircle Enterprise CorporationImporter: Pharmakon Biotec Inc. | DRP-5240-25 | Apr 7, 2029 | |
CeftriakingCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL-capacity USP Type II clear and colorless glass vial sealed with grey bromobutyl rubber stopper and aluminum seal with blue plastic flip-off cap + 10 mL Sterile Water for Injection in USP Type I clear and colorless glass ampoule (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | QLap Endoscopics Inc.Importer: GPC Geo Pharma Corporation | DRP-13950-01 | May 24, 2028 | |
CeftriakingCeftriaxone (as sodium) | 1g Powder for Injection (IM/IV)10 mL-capacity USP type III clear glass vial with rubber stopper and orange flip-off seal and LDPE plastic ampoule x 10 mL for sterile water for injection (diluent) in a plastic tray (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Qlap Endoscopics Inc.Importer: GPC Geo Pharma Corporation | DRP-15190-02 | May 23, 2029 | |
CeftrialisCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M. / I.V.)USP Type I Clear Glass Vial in monocarton (Box of 10) | Rx | Vitalis S.A.C.I.Colombia | Pan-Ject Pharmaceuticals Corp.Trader: Vitalis S.A.C.I. | DRP-2521 | Jan 4, 2030 | |
CeftriamedCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type 1 Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) (Box of 1 Vial & 1 Diluent) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | MXL PharmaImporter: Pharmakon Biotec Inc. | DRP-5240-08 | Apr 7, 2029 | |
CeftriaxcelCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories Ltd.India | Excelpharm CorporationImporter: Ambica International Corporation | DRP-4474-18 | Jun 13, 2028 | |
CeftriaxcelCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Excelpharm CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-14 | Nov 20, 2028 | |
CeftriaxliveCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Each box contains: 1 USP Type I Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type I Clear, Transparent Ampoule (diluent: Sterile Water for Injection) | Rx | Scott-Edil Advance Research Laboratories & Education Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-5240-31 | Apr 7, 2029 | |
CeftriaxsurCeftriaxone (as Sodium) | 1g Powder for Injection (IM/IV)10mL USP Type II clear and colorless glass vial with butyl rubber stopper with flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Pharma-Surrey International, Inc. | DRP-10248 | Aug 20, 2031 | |
CeftribaxCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.).USP type II colorless and transparent glass mould vial with gray bromobutyl rubber stopper and blue aluminum plastic cap x 10 mL (Box of 1's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | GPC Geo Pharma Corporation. | DRP-13695 | Mar 29, 2028 | |
CeftricareCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 5 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories Ltd.India | North Care Pharmaceutical DistributorshipImporter: Ambica International Corporation | DRP-4474-06 | Jun 13, 2028 | |
CeftridecCeftriaxone (as sodium) | 1 g per vial Powder for Injection (IM/IV)USP Type I Glass Vial with Aluminum Seal, Rubber Stopper & Blue Colored Protective Cap + Diluent x 10 mL (Box of 1's) | Rx | Elfin Drugs Pvt. Ltd.India | Deca Med Pharmaceutical Trading Inc.Importer: Divjot Enterprises Corp. | DRP-5799-02 | Dec 13, 2028 | |
CeftridecCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III Clear and Colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile Water for Injection as solvent) (Box of 1's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Deca Pharmaceutical and Trading Corp.Importer: Sanimed Pharmaceuticals Inc. | DRP-7138-14 | Mar 31, 2027 | |
CeftridenCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually Boxed USP Type I Borosilicate Glass Vial with blue flip-off seal x 10 mL (Box of 10's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Cyden Medicale Trading Inc.Importer: AMB HK Enterprises Inc. | DRP-3601-03 | Feb 14, 2029 | |
CeftriexcelCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Soda Lime Glass Vial with Halogenated Rubber Stopper and Aluminum-Plastic Flip-Off Seal + USP Type I Glass Ampoule x 10 mL Water for Injection (Diluent) Box of 1 | Rx | Furen Pharmaceutical Group Co., Ltd.China | MedRep Plus Pharmaceuticals Inc.Importer: Euro-Care Products Philippines | DRP-10961-01 | Dec 22, 2026 | |
CeftrifilCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories Ltd.India | Filadams Pharma, Inc.Importer: Ambica International Corporation | DRP-4474-03 | Jun 13, 2028 | |
CeftrihilCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile water for injection as solvent) [Box of 1's] | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Euroasia Pharmaceuticals, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7138-04 | Mar 31, 2027 | |
CeftrihilCeftriaxone (as sodium) | 1g Powder for Injection (IM/IV)10 mL Capacity USP Type II Tubular Glass Vial with Butyl rubber stopper and Flip-off caps (Box of 10's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | EuroAsia Pharmaceuticals Inc. | DRP-12584 | Sep 8, 2032 | |
CeftrilifeCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories Ltd.India | Ambica International Corporation | DRP-4474 | Jun 13, 2028 | |
CeftrilixCeftriaxone (as Sodium) | 1g Powder for Injection (I.M./I.V.)Type III Colorless Glass Vial (1) + 10 mL Ampoule (Sterile Water for Injection) (Box of 1’s) | Rx | Inject Care Parenterals Pvt. Ltd.India | RCT Med Pharma CorporationImporter: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt.Ltd. | DRP-1140-11 | Feb 19, 2031 | |
CeftrinaCeftriaxone (As Sodium) | 1 g Powder For Injection (IM/IV)Type III clear Colorless Glass Vial with Butyl Rubber Stopper and Capped with Flip-Off Cap x 10 mL (Box of 1’s and 10’s) | Rx | Ncpc Hebei Huamin Pharmaceutical Company LimitedChina | Aglobal Care, Inc. | DRP-10440 | Oct 8, 2031 | |
CeftriniumCeftriaxone (as sodium) | 1g Powder for Injection (I.M/I.V)10mL USP Type III clear and colourless glass vial with grey bromo butyl rubber stopper and aluminium flip off seal + 10mL translucent plastic ampoule (Sterile water for injection) Box of 1 vial + 1 Diluent | Rx | Swiss Parenterals LimitedIndia | Titanium PharmaImporter: Aglobal Care, Inc. | DRP-16534-06 | May 28, 2030 | |
CeftrinovaCeftriaxone (As Sodium) | 500 mg Powder for Injection (IM/IV)10 mL USP Type II Glass Mould Vial with Butyl Rubber Stopper with Flip-off Cap and Sterile Water for Injection in 5 mL Transparent Glass Ampoule (as diluent) [Box of 1's] | Rx | Reyoung Pharmaceutical Co., Ltd.,China | Medinova Pharmaceutical Inc. | DRP-10783 | Nov 19, 2026 | |
CeftriovinnCeftriaxone (as sodium) | 1g Powder for Injection (I.M./I.V.)Box of 1 - Soda lime glass vial with halogenated rubber stopper and aluminum-plastic flip-off seal + USP Type I glass ampoule x 10mL water for injection (Diluent) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Rusann Marketing CorporationImporter: Euro-Care Products Philippines | DRP-10961-02 | Dec 22, 2026 | |
CEFTRIOXCeftriaxone (as sodium) | 1 g per vial Powder for Injection (IM/IV)USP Type I Glass Vial with Aluminum Seal, Rubber Stopper & Blue Colored Protective Cap + Diluent x 10 mL (Box of 1's) | Rx | Elfin Drugs Pvt., Ltd.India | Mandamed Pharma and Medical Supplies TradingImporter: Divjot Enterprises Corp. | DRP-5799-03 | Dec 13, 2028 | |
CeftripanCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL-Capacity USP Type II Glass Vial with Butyl Rubber Stopper and Flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-12797-03 | Oct 7, 2027 | |
Ceftripen 1000Ceftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type III clear glass vial with rubber stopper and white flip-off seal + I0 mL Diluent in glass ampoule (Sterile Water for Injection) (Box of 1 's) | Rx | Zazen Pharma Pvt. Ltd.India | Planetarium Enterprise, Inc.Importer: I.E. Medica, Inc.Trader: Stratgen Healthcare Pvt. Ltd. | DRP-3715-09 | Sep 28, 2028 | |
CeftriphinCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP Type II glass vial with rubber stopper and aluminum blue plastic cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | H & B Pharma International Inc.Importer: Pharmaessence Inc. | DRP-16426-01 | Mar 10, 2030 | |
CeftripremCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type II glass mould vials sealed with gray bromobutyl rubber stopper and blue aluminum plastic cap x 10 mL + clear and transparent USP Type I glass ampoule x 10 mL (net content) Sterile Water for Injection as solvent (Box of 1's; Box of 10's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | Premier Pharmaceuticals Marketing Corp.Importer: Medinova Pharmaceutical Inc. | DRP-13685-07 | Mar 28, 2028 | |
CeftriproCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL-Capacity USP Type II Glass Vial with butyl rubber stopper and flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Compharm, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-12797-02 | Oct 7, 2027 | |
CeftririfeCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile water for injection as solvent) [Box of 1's] | Rx | Zeiss Pharmaceuticals, Pvt. Ltd.India | Rifemedica CorporationImporter: Sanimed Pharmaceuticals Inc. | DRP-7138-10 | Mar 31, 2027 | |
CeftrisaveCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Type III Clear Colorless Glass Vial with Butyl Rubber Stopper and capped with flip-off x 10 mL (Box of 1's and 10's) | Rx | NCPC Hebei Huamin Pharmaceutical CompanyPeople's Republic of China | Savelink Pharma and Trading Co.Importer: AGlobal Care, Inc. | DRP-10440-03 | Oct 8, 2036 | |
Ceftrisave-IVCeftriaxone (as sodium) | 1g Powder for Injection (I.M./I.V)10 mL USP Type III clear and colourless glass vial with grey bromo butyl rubber stopper and aluminium flip off seal + 10 mL translucent plastic ampoule (Sterile water for injection) [Box of 1's] | Rx | Swiss Parenterals LtdIndia | Savelink Pharma and Trading Co.Importer: Aglobal Care, Inc. | DRP-16534-08 | May 28, 2030 | |
CeftrisenzCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP Type II glass vial with rubber stopper and aluminum blue plastic cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., LtdChina | Pharmaessence Inc. | DRP-16426 | Mar 10, 2030 | |
CeftrivinCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually Boxed USP Type I Borosilicate Glass Vial with Blue Flip-Off Seal x 10mL diluent Sterile Water for Injection (BP) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | MDB Pharma TradingImporter: AMB HK Enterprises Inc. | DRP-3601-12 | Feb 14, 2029 | |
CeftrixCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type III Colorless Glass Vial (1) + 10 ml Ampoule (Sterile Water for Injection) Box of 1's | Rx | Inject Care Parenterals Pvt. Ltd.India | Starpharm, Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1140-08 | Dec 8, 2031 | |
CeftrixoneCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)Glass Vial x 10 mL (Box of 1's) and 2 x 5 mL Diluent | Rx | Reyoung Pharmaceutical Co., Ltd.China | Qualifirst Health, Inc. | DR-XY42290 | Jul 29, 2028 | |
CeftronCeftriaxone (As Sodium) | 1 g Powder For Injection (IM/IV)In a box containing 10 mL-capacity USP Type II clear and colorless glass vial sealed with grey bromobutyl rubber stopper and aluminum seal with blue plastic flip-off cap 10 mL-net content Sterile Water for Injection in USP Type I clear and colorless glass ampoule | Rx | Reyoung Pharmaceutical Co., LtdChina | Lakeside Pharmaceuticals Phil., Inc. | DRP-14102 | Jun 21, 2028 | |
CeftroneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories Ltd.India | One Pharma Marketing Inc.Importer: Ambica International Corporation | DRP-4474-16 | Jun 13, 2028 | |
CeftroxCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)USP Type I Glass Vial with Rubber Stopper and Amber 82 Flip-Off Seal + 10 mL Ampoule as Diluent (Box of 1's) | Rx | Singapore Pharmawealth Lifesciences, Inc.Philippines | — | DR-XY35742 | Apr 24, 2029 | |
CeftroxCeftriaxone (as Sodium) | 250 mg Powder for Injection (I.M./I.V.)Type II Clear and Colorless Glass Vial with Rubber Stopper and Aluminum Seal + LDPE Plastic Bottle 5 mL Diluent (Box of 1's) | Rx | Singapore Pharmawealth Lifesciences, Inc.Philippines | — | DR-XY35758 | Apr 29, 2029 | |
CeftroxCeftriaxone (as Sodium) | 500 mg Powder for Injection (I.M./I.V.)Type II Clear and Colorless Glass Vial with Rubber Stopper and Aluminum Seal + 5 mL Diluent Box of 1's | Rx | Singapore Pharmawealth LIfesciences, Inc.Philippines | — | DR-XY35760 | Apr 29, 2029 | |
CefzoxCeftriaxone (as sodium) | 1 g per vial Powder for Injection (IM/IV)USP Type I Glass Vial with Aluminum Seal, Rubber Stopper & Blue Colored Protective Cap + Diluent x 10 mL Box of 1's | Rx | ELFIN DRUGS Pvt., Ltd.India | DIVJOT ENTERPRISES CORP. | DRP-5799 | Dec 13, 2028 | |
CekomCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type I Glass Vial + 10 mL Clear Glass Ampoule Water for Injection (Box of 1's) | Rx | MARC LABORATORIES LTD. (Unit III)India | PHARMAKON BIOTEC INC | DRP-7676 | Mar 27, 2027 | |
CentrexCeftriaxone (as Sodium) | 1g Powder for Injection (IM/IV)Type I Glass Colorless Borosilicate Vial With Flip-off Cap (Box of 10’s) | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | Remker Drug,Inc.Importer: PHIL. SHINPOONG PHARMA INC. | DRP-290-03 | Feb 7, 2032 | |
CephamedCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)USP Type II glass mould vials sealed with gray bromobutyl rubber stopper and blue aluminum plastic cap x 10 mL + clear and transparent USP Type I glass ampoule x 10 mL (net content) Sterile Water for Injection as solvent (Box of 1's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-13685-01 | Mar 28, 2028 | |
CephixoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-4474-02 | Jun 13, 2028 | |
CephradCeftriaxone (as sodium) | 1 g Powder for InjectionIn a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flipoff seal+ LOPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Radbuster Inc.Importer: Greencore Pharma Inc. | DRP-10246-02 | Feb 8, 2032 | |
CEPHTRINCeftriaxone (As Sodium) | 1 g Powder For Injection (IM/IV)USP Type I clear glass vial with red flip-off seal and gray butyl rubber stopper + 10 mL Diluent (Box of 1's) | Rx | PHIL INTER PHARMA CO., LTDVietnam | PHARMA KING DISTRIBUTORImporter: LARGEN MED INC | DRP-5461-04 | Aug 19, 2029 | |
DecacefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Each box contains: 1 USP Type I Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10mL USP Type 1 Clear, Transparent Ampoule (diluent: Sterile Water for Injection) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Decano Drug Distribution ServicesImporter: Pharmakon Biotec Inc. | DRP-5240-27 | Apr 7, 2029 | |
DiatricefCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection Box of 1's | Rx | Brawn Laboratories Ltd.India | Diafarm Inc.Importer: Ambica International Corporation | DRP-4474-10 | Jun 13, 2028 | |
DintriCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile water for injection as solvent) [Box of 1's] | Rx | Zeiss Pharmaceuticals, Pvt. Ltd.India | DNBG Pharmaceuticals Phils.Importer: Sanimed Pharmaceuticals Inc. | DRP-7138-11 | Mar 31, 2027 | |
EftrixCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type I Glass Vial | Rx | Kyung Dong Pharm. Co., Ltd.Republic of Korea | Starpharm, Inc.Importer: H & B Pharma International Inc. | DRP-5834-01 | Sep 12, 2028 | |
EftrixCeftriaxone (as Sodium) | 1g Powder for Injection(IM/IV)Type I Glass Colorless Borosilicate Vial With Flip-off Cap Box of 10’s | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | Starpharm, Inc.Importer: PHIL. SHINPOONG PHARMA INC. | DRP-290-05 | Feb 12, 2032 | |
EfxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Triple Tact Import & Export Corp.Importer: Greencore Pharma Inc. | DRP-10246-03 | Feb 6, 2032 | |
EltriaxoneCeftriaxone (as sodium) | 1g Powder for Injection (IM/IV)10 mL capacity Type III soda lime glass vial with butyl rubber stopper and aluminium plastic cap + USP Type I borosilicate glass ampoule x 10 mL water for injection as diluent (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Asianmeds, Inc.Importer: Euro-Care Products Philippines | DRP-9144-06 | Nov 3, 2030 | |
EnceftrixoneCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories Ltd.India | McTon Pharma Inc.Importer: Ambica International Corporation | DRP-4474-08 | Jun 13, 2028 | |
Eocef-1000Ceftriaxone Sodium | 1 g Powder for Solution for Injection (I.M./I.V.)Clear Glass Vial for Injection x 10mL + 10mL Sterile Water for Injection (Box of 1's) | Rx | Zee Laboratories Ltd.India | Eon Pharmatek, Inc. | DR-XY49444 | Jul 9, 2030 | |
EquicefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)USP Type 1 Clear, Transparent Class Vial with pink flip-off seal (active drug) and 1 10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) (Box of 1 Vial & 1 Diluent) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Healthcare Pharma Co.Importer: Pharmakon Biotec Inc. | DRP-5240-05 | Apr 7, 2029 | |
ErtraxoneCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually boxed USP Type I Borosilicate Glass Vial with Blue Flip-Off Seal (Box of 10's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Bio Erixx Pharma DistributionImporter: AMB HK Enterprises Inc. | DRP-3601-04 | Feb 14, 2029 | |
EurotrixCeftriaxone (Sodium) | 1g Powder for Injection (I.V./I.M.)10 mL Capacity USP Type III Flint Glass Vial with gray Butyl Rubber Stopper and Red Aluminum Flip-off seal (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Eurocare Saver Pharma Co.Importer: Medinova Pharmaceutical Inc. | DRP-10960-02 | Dec 22, 2026 | |
EuroxoneCeftriaxone (as Sodium) | 1 g/vial Powder for Injection (IM/IV)Type I Glass Vial with Rubber Stopper and Green Flip-Off Aluminum Seal + 10 mL diluent (Sterile Water for Injection) in Type I glass ampoule (Box of 1's) | Rx | Shangxi Shuguang Pharmaceutical Co. Ltd.China | Importer: Asianmeds, Inc. | DRP-2060 | Jul 16, 2027 | |
FazactinCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Clear and colorless glass vial with rubber stopper and white flip-off seal (Box of 10’s) | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-976 | Apr 14, 2028 | |
FedtrixCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal+ LDPE Plastic ampoule x 10 mL - diluent Box of 1's | Rx | Theon Pharmaceuticals LimitedIndia | Medical Mission Group Hospitals And Health Services Cooperative Of The Philippines Federation (Mmghhscpf)Importer: Greencore Pharma Inc. | DRP-10246-09 | Feb 8, 2032 | |
FenadefCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt. Ltd.India | Pharmazel, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-09 | Nov 20, 2028 | |
FenadefCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip-Off Seal (Box of 10’s) | Rx | Yungjin Pharm. Co., Ltd.Republic of Korea | Pharmazel, Inc.Importer: Unimex, Inc. | DRP-2137-02 | Aug 2, 2029 | |
FerocepinCeftriaxone (as sodium) | 1g Powder for Injection (IM/IV)15 mL USP Type I Transparent Plain Glass vial (Box of 1's) | Rx | Medisure Laboratories Pakistan (Pvt.) Ltd.Pakistan | Ferjan Healthlink Philippines, Inc.Importer: Accesspoint International Trading Inc. | DRP-11568-01 | Mar 30, 2027 | |
FexoneCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually Boxed USP Type I Borosilicate Glass Vial with blue flip-off seal x 10 mL diluent Sterile Water for Injection (BP) Box of 10's | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | MSF Pharmaceutical Products DistributionImporter: AMB HK Enterprises Inc. | DRP-3601-02 | Feb 14, 2029 | |
Fin-Cef 1Ceftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity type II clear glass vial with rubber stopper and aluminum white flip-off seal (Box of 1's) | Rx | Venus Remedies LimitedIndia | Finstad Inc. | DRP-14651 | Nov 16, 2028 | |
ForgramCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Clear colorless vial + 10 mL clear colorless ampule (Water for Injection-diluent); flip off red and alucap metallic red 20 mm (flip-off cap) (Box of 1's) | Rx | PT Darya-Varia Laboratoria TbkIndonesia | UNILAB, Inc. | DR-XY35813 | May 13, 2029 | |
ForgramCeftriaxone (as sodium) | 500 mg Powder for Injection (IM/IV)Clear Colorless Vial + 5 mL Clear Colorless Ampule (Water for Injection-Diluent); Flip-Off red and Alucap Metallic Red 20 mm (Flip-off Cap) (Box of 1's) | Rx | PT Darya-Varia Laboratoria TbkIndonesia | UNILAB, Inc. | DR-XY35812 | May 13, 2029 | |
ForneumoCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt. Ltd.India | SH & S EnterprisesImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-10 | Nov 20, 2028 | |
ForstanCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity Type I Colorless and transparent glass vial with dark gray rubber closure and blue aluminium cap x 1's (Box of 10's) | Rx | Union Korea Pharm Co., Ltd.Republic of Korea | Ellebasy Medicale Group Inc.Importer: JLT Pharma Inc. | DRP-9065-02 | Dec 1, 2027 | |
FortrixoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | PPAN TradingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940 | Nov 20, 2028 | |
FretriaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Ph. Eur. Type II clear glass vial (Box of 10's) | Rx | Labesfal-Laboratorios Almiro S.A.Portugal | Fresenius Kabi Philippines, Inc. | DR-XY46379 | Jun 18, 2028 | |
FrixoCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal+ LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Ellebasy Medicale Group, Inc.Importer: Greencore Pharma, Inc | DRP-10246-04 | Oct 1, 2031 | |
GavixoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type I Glass Vial with Green Colored Flip-off Seal + Water for Injection 10 mL USP Type I Clear Colorless Glass Ampoule (Box of 1's) | Rx | Zhuhai Kinhoo Pharmaceutical Co., Ltd.China | Ellebasy Medicale TradingImporter: Sahar International Trading Inc. | DRP-5929-01 | Sep 30, 2028 | |
GeftriCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile water for injection as solvent) [Box of 1's] | Rx | \Zeiss Pharmaceuticals, Pvt. Ltd.India | Greentech Life Sciences Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7138-07 | Mar 31, 2027 | |
GentraxoneCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)10 mL - Capacity USP Type III Flint Glass with Grey Butyl Rubber Stopper and Red Aluminum Flip-off Seal (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-10960-01 | Dec 22, 2026 | |
GentriaxoneCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually Boxed USP Type I Borosilicate Glass Vial with Blue Flip-Off Seal x 10 mL diluent Sterile Water for Injection (BP) (Box of 1's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Genzen Pharmaceutical TradingImporter: AMB HK Enterprises Inc. | DRP-3601-09 | Feb 14, 2029 | |
GentriaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type 1 Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) (Box of 1 Vial & 1 Diluent) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Genzen Pharmaceutical TradingImporter: Pharmakon Biotec Inc. | DRP-5240-20 | Apr 7, 2029 | |
GentrixCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V)Soda Lime Glass Vial with Halogenated butyl rubber stopper and aluminum plastic cap (Box of 10's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-12457-01 | Aug 16, 2027 | |
GENXONECEFTRIAXONE (AS SODIUM) | 1g Powder for Injection (IM/IV)SP Type I clear glass vial with red flip-off seal and gray butyl rubber stopper + 10mL diluents (Box of 1's) | Rx | PHIL INTER PHARMA CO., LTDVietnam | DYNASTY PHARMACEUTICALSImporter: LARGEN MED INC | DRP-5461-02 | Aug 18, 2029 | |
GenzoneCeftriaxone (as sodium) | 1g Powder for Injection (IM/IV)10 mL-capacity USP type II glass vial with gray bromobutyl rubber stopper and blue aluminum plastic cap. (Box of 1's with Diluent) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Largen Med Inc.Importer: Dreamax Incorporated | DRP-11898-07 | May 18, 2027 | |
GeotrixxCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)USP Type I clear glass vial with gray chlorobutyl rubber and blue aluminum cap (Box of 1 's and 10's) | Rx | Kyongbo Pharmaceutical Co., Ltd.Republic of Korea | Bell-Kenz Pharma Inc.Importer: GPC Geo Pharma CorporationTrader: Daewon Pharm. Co. Ltd. | DRP-7533 | Dec 1, 2027 | |
GeoxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP type III clear glass vial with rubber. stopper and orange flip-off seal and LDPE plastic ampoule x 10 mL for sterile water for injection (diluent) in a plastic tray (Box of 1's) | Rx | Swiss Parenterals Ltd.India | GPC Geo Pharma Corporation | DRP-15190 | May 23, 2029 | |
GidixoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Gdmed Pharma DistributorImporter: Greencore Pharma, Inc. | DRP-10246-14 | Oct 1, 2031 | |
GifixonCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type I Glass Vial (Box of 10's) | Rx | Kyung Dong Pharm Co., Ltd.Republic of Korea | Ma Conglomo Med Corp.Importer: H & B Pharma International Inc. | DRP-5834-08 | Sep 12, 2028 | |
GifixonCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Glass Vial with blue flip-off seal and gray butyl rubber stopper Box of 10's | Rx | AJU PHARM CO., LTD.Republic of Korea | GIJUN TRADING INC.Importer: JAZMARK PHARMACEUTICAL | DRP-6779-06 | Apr 15, 2029 | |
GioxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flipoff seal+ LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Euro-Care Products PhilippinesImporter: Greencore Pharma Inc. | DRP-10246-05 | Feb 8, 2032 | |
GioxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Type I glass vial with butyl rubber stopper with aluminum seal and blue flip-off cap + 10 mL Sterile Water for Injection (diluent) in plastic tray (Box of 1's) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Euro-Care Products PhilippinesImporter: Asianmeds, Inc. | DRP-13416-01 | Feb 27, 2028 | |
GixoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceutical LimitedVillage & P.o Saiini Majira Tehsil Nalagarh 174 101 Himachal Pradesh India | Gijun Trading Inc.Importer: Greencore Pharma Inc. | DRP-10246-15 | Oct 1, 2031 | |
GixoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type 1 Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Gijun Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-5240-16 | Apr 7, 2029 | |
GoceftCeftriaxone (as Sodium) | 1g Powder for Injection (I.V./I.M.)10 mL-Capacity USP Type III Flint Glass Vial with grey butyl rubber stopper and red Aluminum flip-off seal (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Generic Option Pharma Corp. | DRP-10958 | Dec 22, 2026 | |
GotaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type II glass mould vials sealed with gray bromobutyl rubber stopper and blue aluminum plastic cap x 10 mL + clear and transparent USP Type I glass ampoule x 10 mL (net content) Sterile Water for Injection as solvent (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Go Healthcare Pharmaceutical DistributionImporter: Medinova Pharmaceutical Inc. | DRP-13685-03 | Mar 28, 2028 | |
Gotaxone IVCeftriaxone (as sodium) | 1g Powder for Injection (I.M./I.V.)Soda lime glass vial with halogenated rubber stopper and aluminum-plastic flip-off seal + USP Type I Glass Ampoule x 10 mL Water for Injection (Diluent) (Box of 1) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Go Healthcare Pharmaceutical DistributionImporter: Euro-Care Products Philippines | DRP-10961-08 | Dec 22, 2026 | |
Gotaxone IVCeftriaxone (as sodium) | 1g Powder for Injection (IM/IV)10 mL capacity Type III soda lime glass vial with butyl rubber stopper and aluminium plastic cap + USP Type I borosilicate glass ampoule x 10 mL water for injection as diluent (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | GO Healthcare Pharmaceutical DistributionImporter: Euro-Care Products Philippines | DRP-9144-02 | Nov 3, 2030 | |
GotraxCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually Boxed USP Type I Borosilicate Glass Vial with Blue Flip-Off Seal x 10 mL diluent Sterile Water for Injection (BP) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Applied Pharmaceutical Distribution IncImporter: AMB HK Enterprises Inc. | DRP-3601-10 | Feb 14, 2029 | |
GotriaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule with Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Applied Pharmaceutical Distribution, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-05 | Nov 20, 2028 | |
GotrioneCeftriaxone (as sodium) | 1g Powder for injection (IM/IV)10 mL- capacity USP Type II glass vial with gray bromobutyl rubber stopper and blue aluminum plastic cap (Box of 1’s) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Go-Life PharmaImporter: Dreamax Incorporated | DRP-11898-05 | May 18, 2027 | |
GoxoneCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually boxed USP Type I Borosilicate Glass Vial with Blue Flip-Off Seal (Box of 10's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc. | DRP-3601-8 | Feb 14, 2029 | |
GrexoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type 1 Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) (Box of 1 Vial & 1 Diluent) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Greentech Life Sciences Inc.Importer: Pharmakon Biotec Inc. | DRP-5240-23 | Apr 7, 2029 | |
GroxoneCeftriaxone (as sodium) | 1 g Powder for injection (IV/IM)USP Type III Clear and Colorless Glass Vial with Red Flip-off Seal (Box of 1's and 10's) | Rx | YELURI FORMULATIONS PVT. LTD.India | GROVIC PHARMA INC. | DRP-3815 | Jun 28, 2029 | |
GY-TrioneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | G.Y. TradingImporter: Greencore Pharma Inc. | DRP-10246-18 | Oct 1, 2031 | |
GY-TrixoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP Type II glass vial with rubber stopper and aluminum blue plastic cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Grabernoll Pharmaceutical CorporationImporter: Pharmaessence Inc. | DRP-16426-02 | Mar 10, 2030 | |
HaixoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Greencore Pharma Inc. | DRP-10246 | Oct 1, 2031 | |
HantoxCeftriaxone (as sodium) | 1 g Powder for Injection (IV)15 mL-capacity transparent glass vial with aluminum red flip-off seal (Box of 1's) | Rx | Hansel Pharmaceuticals (Pvt.)Pakistan | Zuneca Incorporated | DRP-14814 | Jan 15, 2029 | |
HaxonCeftriaxone (as Sodium) | 1g Powder for Injection (I.M./I.V.)USP Type III glass vial + 10mL Sterile Water for Injection in USP Type I glass ampoule (Box of 1's) | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Endure Medical, Inc. | DR-XY34155 | Jan 22, 2028 | |
HaxonCeftriaxone (as Sodium) | 1g Powder for Injection (I.M./I.V.)USP Type III glass vial + 10mL Sterile Water for Injection in USP Type I glass ampoule (Box of 1's) | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Endure Medical, Inc. | DRP-16399 | Jan 22, 2028 | |
HaxonCeftriaxone (as Sodium) | 1g Powder for Injection (IM/IV)USP Type 1 Colorless Glass Vial with rubber stopper and blue flip-off seal (Box of 10's) | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Endure Medical, Inc. | DR-XY33749 | Aug 21, 2027 | |
HaxonCeftriaxone (as Sodium) | 250 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial with rubber stopper and blue flip-off seal + 5 mL Water for Injection in glass ampoule (Box of 1's) | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Endure Medical, Inc. | DR-XY34287 | Feb 19, 2028 | |
HaxonCeftriaxone (as Sodium) | 250 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial with rubber stopper and blue flip-off seal + 5 mL Water for Injection in glass ampoule (Box of 1's) | Rx | Harbin Pharmaceutical Group Co., Ltd General Pharm. FactoryChina | Endure Medical, Inc. | DRP-16345 | Feb 19, 2028 | |
HaxonCeftriaxone (as Sodium) | 500 mg Powder for Injection (I.M./I.V.)USP Type I glass vial with rubber stopper and blue flip-off seal + 5 mL Sterile Water for Injection in glass ampoule (Box of 1's) | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Endure Medical, Inc. | DR-XY34283 | Feb 19, 2028 | |
HaxonCeftriaxone (as Sodium) | 500 mg Powder for Injection (I.M./I.V.)USP Type I glass vial with rubber stopper and blue flip-off seal + 5 mL Sterile Water for Injection in glass ampoule (Box of 1's) | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Endure Medical, Inc. | DRP-16346 | Feb 19, 2028 | |
HaxonCeftriaxone (as Sodium) | 500 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip-off Seal Box of 10's | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Endure Medical, Inc. | DR-XY33746 | Aug 21, 2027 | |
HeraxoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type II glass mould vials sealed with gray bromobutyl rubber stopper and blue aluminum plastic cap x 10 mL + clear and transparent USP Type I glass ampoule x 10 mL (net content) Sterile Water for Injection as solvent. (Box of 1's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | Herald's Pharma and Medical Supplies DistributionImporter: Medinova Pharmaceutical Inc. | DRP-13685-08 | Mar 28, 2028 | |
HeraxoneCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)USP Type III Clear Glass Vila with Green colored flip-off seal (Box of 1's and 10's without diluent) | Rx | SYNCOM FORMULATIONS (INDIA) LTD.India | HERALD'S PHARMA AND MEDICAL SUPPLIES DISTRIBUTIONImporter: ARVINCARE PHARMA INC. | DRP-1084-05 | Jun 8, 2028 | |
HerixonCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)10 mL Capacity USP Type III Clear and Colorless Glass Vial with Grey Bromo Butyl Rubber Stopper and Dark Blue Flip-Off Seal (Box of 1's) | Rx | Theon Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DR-XY46813 | Jan 24, 2030 | |
HoftrexCeftriaxone (as Sodium) | 1g Powder for Injection (IM/IV)20mL USP Type 1 Clear Glass Vial (Box of 1 vial + LDPE ampoule containing 10mL of Sterile Water for Injection as diluent) | Rx | Nectar Lifesciences Limited (Unit VI)India | Hovid Inc.Trader: Hovid Bhd. | DR-XY41415 | Nov 19, 2027 | |
InfiobioticCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity type I clear glass vial with rubber stopper and blue aluminum flip-off seal (Box of l’s) | Rx | PT. BernofarmIndonesia | Dreamax Incorporated | DRP-12010 | May 30, 2027 | |
IvixoneCeftriaxone (as sodium) | 1 g Powder For Injection (IV/IM)10 mL-capacity USP Type-III clear flint glass vial with grey rubber stopper and light blue aluminum flip off seal (Box of 1's) | Rx | Vhb Medi Sciences LimitedIndia | Brady Pharma Inc. | DR-XY49786 | Aug 12, 2031 | |
IvtreneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type I Glass Vial (Box of 10's) | Rx | Kyung Dong Pharm Co., Ltd.Republic of Korea | Aisec Farma CorporationImporter: H & B Pharma International Inc. | DRP-5834 | Sep 12, 2028 | |
IvtrenseCeftriaxone (as Sodium) | 1g Powder for Injection (IM/IV)Type I Glass Colorless Borosilicate Vial with Flip-off Cap (Box of 10’s) | Rx | Shin Poong Pharmaceutical Co., Ltd.Republic of Korea | Aisec Farma CorporationImporter: Phil. Shinpoong Pharma, Inc. | DRP-290-06 | Apr 11, 2031 | |
J-TrixCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule with Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | 228 Pharma TradingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-07 | Nov 20, 2028 | |
JazeftCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type I Glass Vial (Box of 10's) | Rx | Kyung Dong Pharm Co., Ltd.Republic of Korea | Pharma King DistributorImporter: H & B Pharma International Inc. | DRP-5834-07 | Sep 12, 2028 | |
JazeftCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type I Clear Glass Vial with Blue Flip-Off Seal and Gray Butyl Rubber Stopper (Box of 10’s) | Rx | Aju Pharm Co., Ltd.Republic of Korea | Pharma King DistributorImporter: Jazmark Pharmaceutical | DRP-6779-01 | Apr 15, 2029 | |
JazfixCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type I Glass Vial | Rx | Kyung Dong Pharm Co., Ltd.Republic of Korea | Tamiga Pharmaceuticals SupplyImporter: H & B Pharma International Inc. | DRP-5834-05 | Sep 12, 2028 | |
Jutrixone 1GCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)Box of 1- Soda lime glass vial with halogenated rubber stopper and aluminum-plastic flip-off seal + USP Type I Glass Ampoule x 10 mL Water for Injection (Diluent) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Jusan Pharmaceuticals Distributor & SupplyImporter: Euro-Care Products Philippines | DRP-10961-07 | Dec 22, 2026 | |
Jutrixone 1GCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL capacity Type III soda lime glass vial with butyl rubber stopper and aluminium plastic cap + USP Type I borosilicate glass ampoule x 10 mL water for injection as diluent (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Jusan Pharmaceuticals Distributor & SupplyImporter: Euro-Care Products Philippines | DRP-9144-03 | Nov 3, 2030 | |
KairoxonCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Pharmacom DistributionImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-01 | Nov 20, 2028 | |
KatnissCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III Clear and Colorless Glass Vial sealed with 20 mm Grey Bromobutyl Rubber Stopper and Blue Flip-off Seal + 10 mL Plastic Ampoule (Sterile water for Injection as solvent) Box of 1's | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Sanoviz Pharmaceutical Products TradingImporter: Sanimed Pharmaceuticals Inc. | DRP-7138-13 | Mar 31, 2027 | |
KcefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Each box contains: 1 USP Type 1 Clear, Transparent Class Vial with pink flip-off seal (active drug) and 1 10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | JKA Pharma and Medical Supplies DistributionImporter: Pharmakon Biotec Inc. | DRP-5240-24 | Apr 7, 2029 | |
KenaxefCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial with Gray Butyl Rubber Closure and Sealed with Aluminum Cap and Red Flip-off Plastic Cap x 25 mL (Box of 10’s) | Rx | Chong Kun Dang Pharmaceutical Co., LtdRepublic of Korea | D & G PharmaImporter: Unimex, Inc. | DRP-7840-01 | Feb 1, 2032 | |
KeptrixCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Colorless glass (Type I) vial w/ bromobutyl rubber stopper, sealed with tear-off aluminum seal and white flip-off plastic cap x 15 mL + Clear colorless Type I Glass Ampoule x 10 mL Sterile Water for Injection (Solvent) (Box of 1's) | Rx | Biolab Co., Ltd.Thailand | The Cathay Drug Co., Inc. | DR-XY27137 | Sep 13, 2036 | |
KnopxoneCeftriaxone (as sodium) | 1g Powder for Injection10 mL USP Type III clear and colourless glass vial with grey bromo butyl rubber stopper and aluminium flip off seal + 10 mL translucent plastic ampoule (Sterile water for injection) [Box of 1's] | Rx | Swiss Parenterals LimitedIndia | Knopper TradingImporter: Aglobal Care, Inc. | DRP-16534-09 | May 28, 2030 | |
Lariax-1Ceftriaxone (as sodium) | 1g Powder for Injection (IM/IV)10 mL-capacity USP type II glass vial with gray bromobutyl rubber stopper and blue aluminum plastic cap + 10 mL Sterile Water for Injection (Box of 1’s ) | Rx | Reyoung Pharmaceutical Co., Ltd.China | D & G PharmaImporter: Dreamax Incorporated | DRP-11898-08 | May 18, 2027 | |
LariaxoneCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Colorless Glass Vial (Box of 10's) | Rx | Phil Inter Pharma Co., Ltd. (Plant 2)Vietnam | D&G PharmaImporter: Largen Med Inc. | DRP-4718-04 | Nov 8, 2027 | |
LarzanCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./ I.V.)USP Type I Clear Colorless Glass Vial (Box of 10's) | Rx | Phil Inter Pharma Co., Ltd. (Plant 2)Vietnam | Checktrade Pharma, Inc.Importer: Largen Med Inc. | DRP-4718-03 | Nov 8, 2027 | |
LevetraxCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flipoff seal + LDPE Plastic ampoule x 10 mL - diluent Box of 1's | Rx | Theon Pharmaceuticals LimitedIndia | Hlm Pharmaceutical, Inc.Importer: Greencore Pharma, Inc. | DRP-10246-01 | Oct 1, 2031 | |
LevetriaxCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt. Ltd.India | HLM Pharmaceutical Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-17 | Nov 20, 2028 | |
LifetrixoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule with Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Bio Medpro PharmaceuticalsImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-06 | Nov 20, 2028 | |
LoricefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP type III clear glass vial with rubber stopper and aluminum green flip-off seal (Box of 1's) (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Loriel PharmaceuticareImporter: Afree Pharmaceutical Distribution Corp. | DRP-14007-02 | Jun 5, 2028 | |
LourceftCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)Box of 1 - Soda lime glass vial with halogenated rubber stopper and aluminum-plastic flip-off seal + USP Type I Glass Ampoule x 10 mL Water for Injection (Diluent) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Ritegen Inc.Importer: Euro-Care Products Philippines | DRP-10961-03 | Dec 22, 2026 | |
LuoriaxonCeftriaxone (as sodium) | 1 g Powder for Solution for Injection (IM/IV)/InfusionMolded Soda Lime Injection Vials with Coated Halogenated Butyl Rubber Stopper & Aluminum-Plastic Combination Cap x 10 mL (Box of 1 vial) | Rx | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.China | Luoxin Pharmaceuticals (PH) Corp. | DR-XY49095 | May 27, 2029 | |
LuotriaxoneCeftriaxone | 500 mg Powder for Solution for Injection (IM/IV)/ InfusionMolded Soda Lime Injection Vials with Coated Brominated Butyl Rubber Stopper & Aluminum-Plastic Combination Cap x 7 mL (Box of 1 vial) x 7 mL (Box of 1 vial) | Rx | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.China | Luoxin Pharmaceuticals (PH) Corp. | DR-XY49094 | May 27, 2029 | |
MarecefCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type III clear glass vial with rubber stopper and white flip-off seal + I0 mL Diluent in glass ampoule (Sterile Water for Injection) (Box of 1's) | Rx | Zazen Pharma Pvt. Ltd.India | Vivilon Pharmaceuticals Inc.Importer: I.E. Medica, Inc.Trader: Stratgen Heathcare Pvt. Ltd. | DRP-3715-10 | Sep 28, 2028 | |
MartriaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL - capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Aqua-MaxImporter: Greencore Pharma Inc. | DRP-10246-13 | Feb 8, 2032 | |
MedaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IV/IM)10 mL-capacity Type I clear glass vial with grey rubber stopper and aluminum cap (Box of 1's) | Rx | Medochemie Ltd (Factory C)Cyprus | Detoxicare Phils., Inc. | DRP-8854 | Sep 17, 2030 | |
MedceftCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)USP Type III clear glass vial with rubber stopper and white flip-off seal+ 10 mL Diluent in glass ampoule (Sterile Water for Injection) (Box of 1's) | Rx | ZAZEN PHARMA PVT. LTD.India | Vivilon Pharmaceuticals inc.Importer: I.E. Medica, Inc.Trader: Stratgen Healthcare Pvt. Ltd. | DRP-3715-06 | Sep 28, 2028 | |
MeditrixCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)USP Type Ill clear glass vial with rubber stopper and white flip-off seal + 10 mL Diluent in glass ampoule (Sterile Water for Injection) (Box of 1's) | Rx | Zazen Pharma Pvt. Ltd.India | Medarruz Pharmaceutical Philippines Inc.Importer: I.E. Medica, Inc.Trader: Stratgen Healthcare Pvt. Ltd. | DRP-3715-04 | Sep 28, 2028 | |
MedtaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type II glass mould vials sealed with gray bromobutyl rubber stopper and blue aluminum plastic cap x 10 mL clear and transparent USP Type I glass ampoule x 10 mL (net content) Sterile Water for Injection as solvent (Box of 1's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | Medinova Pharmaceutical Inc. | DRP-13685 | Mar 28, 2028 | |
MedtriCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories Ltd.India | Marilz Pharmaceuticals CorporationImporter: Ambica International Corporation | DRP-4474-07 | Jun 13, 2028 | |
MedtrixonCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually Boxed USP Type I Borosilicate Glass Vial with blue flip-off seal x 10 mL diluent Sterile Water for Injection (Box of 10's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Southmed Pharma CorporationImporter: AMB HK Enterprises Inc. | DRP-3601-05 | Feb 14, 2029 | |
MedtrixonCeftriaxone (as sodium) | 1g Powder for Injection (I.M./I.V.)10 mL USP Type III clear and colourless glass vial with grey bromo butyl rubber stopper and aluminium flip off seal + 10 mL translucent plastic ampoule (Sterile water for injection) (Box of 1 vial + 1 Ampoule Diluent) | Rx | Swiss Parenterals LimitedIndia | Southmed Pharma CorporationImporter: Aglobal Care, Inc. | DRP-16534-07 | May 28, 2030 | |
MedxoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type II glass mould vials sealed with gray bromobutyl rubber stopper and blue aluminum plastic cap x 10 mL + clear and transparent USP Type I glass ampoule x 10 mL (net content) Sterile Water for Injection as solvent. (Box of 1's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | Blue Medceuticals Marketing Corp.Importer: Medinova Pharmaceutical Inc. | DRP-13685-06 | Mar 28, 2028 | |
MedzefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Colorless Type I Glass Vial (Box of 10’s) | Rx | SAMJIN PHARMACEUTICAL CO., LTD.Republic of Korea | MEDBRIDGE, INC.Importer: UNIMEX, INC. | DRP-4203-01 | May 26, 2027 | |
MidtrixCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule with Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Zionmed Medical Supplies TradingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-04 | Nov 20, 2028 | |
Mitriax 1Ceftriaxone (as Sodium) | 1 g Powder For Injection (IV/IM)10 mL-Capacity USP Type III Clear Glass Vial with grey butyl rubber stopper and aluminium flip-off seal (Box of 1’s) | Rx | Makcur Laboratories LimitedIndia | Penta Labs Australia (Philippines)Trader: U Square Lifesciences Pvt. Ltd. | DRP-10959 | Dec 22, 2026 | |
NeocefriaxCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Neodrugs Pharma and Medical Supplies DistributionImporter: Greencore Pharma Inc. | DRP-10246-17 | Oct 1, 2031 | |
NeozefraxCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection Box of 1's | Rx | Brawn Laboratories Ltd.India | Neo-Care PhilippinesImporter: Ambica International Corporation | DRP-4474-13 | Jun 13, 2028 | |
New AmbicephCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories Ltd.India | Pharmalife DistributionImporter: Ambica International Corporation | DRP-4474-14 | Jun 13, 2028 | |
New AmbicephCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear glass vial with grey bromo butyl rubber stopper and flip-off orange-coloured aluminum seal x 1's (Box of 1's) | Rx | Innova Captab LimitedIndia | Pharmalife DistributionImporter: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-3242-04 | Feb 8, 2028 | |
NewceftCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP type III clear glass vial with rubber stopper and aluminum blue flip-off seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Newman Pharmaceuticals CorporationImporter: Afree Pharmaceutical Distribution Corp. | DRP-14007-03 | Jun 5, 2028 | |
NICOTRIXCeftriaxone (as Sodium) | 1g Powder for Injection (IM/IV)USP Type III Clear Glass Vial with Green-colored Flip-off Seal (Box of 1's) | Rx | SYNCOM FORMULATIONS (INDIA) LTD.India | THYMED ENTERPRISESImporter: ARVINCARE PHARMA INC. | DRP-1084-01 | Jun 8, 2028 | |
NikkoxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL Type III glass vial with grey bromobutyl rubber stopper, aluminum seal and blue plastic flip-off cap + 10 mL LDPE ampoule SWFI (diluent) in plastic tray (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Nikkos Pharmaceutical Products DistributionImporter: Sanimed Pharmaceuticals Inc. | DRP-14065-02 | Jun 13, 2028 | |
NikkoxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile water for injection as solvent) [Box of 1's and 10's] | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Nikkos Pharmaceuticals Product DistributionImporter: Sanimed Pharmaceuticals Inc. | DRP-7138-18 | Mar 31, 2027 | |
NirixoneCeftriaxone (as Sodium) | 1g Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial + 10mL Sterile Water for Injection in Plastic Ampoule (Box of 1's) | Rx | Aculife Healthcare Private LimitedIndia | HLN Philippines Trading Inc. | DR-XY44961 | Dec 28, 2027 | |
NjectxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type 1 Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | NJT EnterprisesImporter: Pharmakon Biotec Inc. | DRP-5240-02 | Apr 7, 2029 | |
NoneCeftriaxone (as sodium) | 1 g Powder For Injection10 mL USP Type III clear and colourless glass vial with grey bromo butyl rubber stopper and aluminum flip off seal + 10 mL transluscent plastic ampoule (Sterile water for injection) (Box of 1 vial + 1 diluent) | Rx | Swiss Parenterals Ltd.India | Connectwell Pharma Inc.Importer: AGlobal Care, Inc. | DRP-16534-04 | May 28, 2030 | |
NoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M. / I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1’s) | Rx | Brawn Laboratories Ltd.India | Hiquality Meds, Inc.Importer: Ambica International Corporation | DRP-4474-17 | Jun 13, 2028 | |
NoneCeftriaxone Sodium | 1 g Powder for Injection (I.M./I.V.)1 g USP Type I Clear Glass Vial with Rubber Stopper and Red Flip-Off Seal + 10 mL Ampoule (Diluent) (Box of 1's) | Rx | Bosch Pharmaceuticals (Pvt.) Ltd.Pakistan | Nueva Sunshine Phils., Inc.Importer: Sahar International Trading Inc. | DRP-13818-01 | Oct 2, 2028 | |
NoneCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip-Off Seal (Box of 10’s) | Rx | Yungjin Pharm. Co., Ltd.Republic of Korea | D & G PharmaImporter: Unimex, Inc. | DRP-2137-06 | Aug 2, 2029 | |
NoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I flint glass vial sealed with 20 mm grey bromo butyl rubber stopper and a flip off aluminum seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-9353 | Dec 4, 2030 | |
NoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL Type III glass vial with grey bromobutyl rubber stopper, aluminum seal and blue plastic flip-off cap + 10 mL LDPE ampoule SWFI (diluent) in plastic tray (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Pharmasilv TradingImporter: Sanimed Pharmaceuticals Inc. | DRP-14065-07 | Jun 13, 2028 | |
NoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP type III clear glass vial with rubber stopper and green flip-off seal and LDPE plastic ampoule x 10 mL for sterile water for injection (diluent) in a plastic tray (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Bell-Kenz Pharma, Inc.Importer: GPC Geo Pharma Corporation | DRP-15190-03 | May 23, 2029 | |
NoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Type I Vial with Aluminum Seal and Red Flip-off Cap x 15 mL (Box of 10's) | Rx | Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., Ltd.China | Dynasty Pharmaceuticals | DRP-7481 | Mar 12, 2037 | |
NoneCeftriaxone (as sodium) | 1 g Powder for Injection (IV/IM)10 mL-capacity Type III clear glass vial with grey rubber stopper and purple aluminum flip off seal Box of 1's | Rx | Nectar Lifesciencs Limited (Unit VI)India | Ritemed Phils., Inc. | DR-XY46942 | Nov 10, 2030 | |
NoneCeftriaxone (as Sodium) | 1g Powder for Injection (I.M./I.V.)USP Type III glass vial + 10mL Sterile Water for Injection in USP Type I glass ampoule (Box of 1's) | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Phil Pharmawealth, Inc.Importer: Endure Medical, Inc. | DRP-16399-01 | Jan 22, 2028 | |
NoneCeftriaxone (as sodium) | 2 g Powder for Injection (IM/IV)20 mL-capacity USP Type III Clear Glass Vial with rubber stopper and aluminum grey flip-off seal (Box of 1's) | Rx | Vellinton HealthcareIndia | Pranish Inc. | DRP-14989 | Dec 20, 2028 | |
NoneCeftriaxone (as Sodium) | 250 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial with rubber stopper and blue flip-off seal + 5 mL Water for Injection in glass ampoule (Box of 1's) | Rx | Harbin Pharmaceutical Group Co., Ltd General Pharm. FactoryChina | Phil Pharmawealth, Inc.Importer: Endure Medical, Inc. | DRP-16345-01 | Feb 19, 2028 | |
NoneCeftriaxone (as Sodium) | 500 mg Powder for Injection (I.M./I.V.)USP Type I glass vial with rubber stopper and blue flip-off seal + 5 mL Sterile Water for Injection in glass ampoule (Box of 1's) | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Phil Pharmawealth, Inc.Importer: Endure Medical, Inc. | DRP-16346-01 | Feb 19, 2028 | |
NorcephinCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)USP Type III Clear Glass Vial with Green Colored Flip-off Seal (Box of 1's) | Rx | SYNCOM FORMULATIONS (INDIA) LTD.India | BANSAN PHARMA DISTRIBUTORImporter: ARVINCARE PHARMA INC. | DRP-1084-03 | Jun 8, 2028 | |
NovaxoneCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)USP Type I Glass Vial x 10 mL (Box of 1's) | Rx | Sance Laboratories Pvt. Ltd.India | Medinova Pharmaceutical Inc. | DRP-5965 | Jan 29, 2030 | |
NovixonCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile water for injection as solvent) [Box of 1's and 10's] | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Sanimed Pharmaceuticals Inc. | DRP-7138 | Mar 31, 2027 | |
NovtrixCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Soda lime glass vial with halogenated butyl rubber stopper and aluminum plastic cap (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Medinova Pharmaceutical Inc. | DRP-12457 | Aug 16, 2027 | |
NoxoramCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)USP Type III Clear Glass Vial with Green Colored Flip-off Seal (Box of 1's) | Rx | SYNCOM FORMULATIONS (INDIA) LTD.India | ARVINCARE PHARMA INC. | DRP-1084-04 | Jun 8, 2028 | |
NumetraxCeftriaxone (as Sodium) | 1g Powder for Injection(IM/IV)Type I Glass Colorless Borosilicate Vial With Flip-off Cap (Box of 10’s) | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | Elin Pharmaceuticals Inc.Importer: PHIL. SHINPOONG PHARMA INC. | DRP-290-04 | Apr 11, 2031 | |
OnafixCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type I Glass Vial | Rx | Kyung Dong Pharm Co., Ltd.Republic of Korea | Medirich Pharma Distribution Corp.Importer: H & B Pharma International Inc. | DRP-5834-04 | Sep 12, 2028 | |
OncefCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)USP Type 1 Glass Vial with Orange Cap-Off Seal (Box of 10's) | Rx | Dae Han New Pharm. Co. Ltd.Korea | Medhaus Pharma, IncorporatesImporter: Euro-Health Care Exponents, Inc. | DR-XY44049 | Jan 12, 2030 | |
One-TriaxcelCeftriaxone (As Sodium) | 1 g Powder For Injection (IM/IV)USP Type III Clear Colorless Glass Vial Sealed with Grey Butyl Rubber Stopper and Red Flip-off Seal x 10 mL (Box of 1's) | Rx | Swiss Parenterals Ltd.India | One Dexcel Pharma Inc. | DRP-11081 | Jan 26, 2027 | |
OnefixCeftriaxone (as sodium) | 1 g Powder for injection (I.M. / I.V.)10 mL Capacity USP Type III Clear and Colorless Glass Vial with Grey Bromo Butyl Rubber Stopper and Dark Blue Flip-off Seal Box of 10's | Rx | Theon Pharmaceuticals LimitedIndia | HEXAGON PHARMACEUTICALS | DR-XY46814 | Jan 24, 2030 | |
PeftrinCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually boxed USP Type I Borosilicate Glass Vial with blue flip-off seal x 10 mL diluent Sterile Water for Injection BP Box of 10's | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-3601-01 | Feb 14, 2029 | |
PhiltrixCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually Boxed USP Type I Borosilicate Glass Vial with blue flip-off seal x 10 mL diluent Sterile Water for Injection (BP) (Box of 10's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-3601-06 | Feb 14, 2029 | |
PhysicxoneCeftriaxone (as sodium) | 1 g Powder for InjectionBox of 1 - Soda lime glass vial with halogenated rubber stopper and aluminum-plastic flip-off seal + USP Type I Glass Ampoule x 10 mL Water for Injection (Diluent) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Physics Pharmaceutical TradingImporter: Euro-Care Products Philippines | DRP-10961-6 | Dec 22, 2026 | |
PlaxoneCeftriaxone sodium | 1 g Powder for Injection (I.V./I.M.)USP Type III clear and colorless glass vial with red flip-off seal (Box of 1's and 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Central West Medicale Inc.Importer: Grovic Pharma Inc. | DRP-3815-01 | Jun 28, 2029 | |
PneumosolvCeftriaxone (as sodium) | 1 g Powder for Injection10 mL USP Type III clear and colourless glass vial with grey bromo butyl rubber stopper and aluminium flip off seal + 10 mL translucent plastic ampoule (Sterile water for injection) (Box of 1's) | Rx | Swiss Parenterals Ltd.India | JustRight Healthcare Inc.Importer: AGlobal Care, Inc. | DRP-16534-02 | May 28, 2030 | |
PneumosolvCeftriaxone (as sodium) | 1 g Powder For Injection (IM/IV)Type II Glass Vial x 10 mL with Butyl Rubber Stopper and Flip-off Seal + 10 mL Ampoule Sterile Water for Injection (Diluent) (Box of 1's) | Rx | Utopian Co., Ltd.Thailand | Justright Healthcare Inc | DR-XY49741 | Jul 13, 2031 | |
PneumosolvCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)20 mL Type III round clear glass vial with red rubber stopper enclosed with aluminum cap + 10 mL Type I clear glass ampoule Sterile Water for Injection diluent | Rx | M&H Manufacturing Co., Ltd.Thailand | JustRight HealthCare Inc.Importer: GPC Geo Pharma Corporation | DRP-15143-01 | May 13, 2029 | |
1 g Powder For Injection (IM/IV)USP Type I clear glass vial with red flip-off seal and gray butyl rubber stopper + 10mL diluent (Box of 1's) | Rx | Phil Inter Pharma Co., Ltd.Vietnam | Justright Healthcare Inc.Importer: Largen Med., Inc. | DRP-5461-01 | Aug 28, 2029 | ||
PneumosolvCeftriaxone (as sodium) | 1 g Sterile Powder for Injection (I.M./I.V.)USP Type I Glass Vial with butyl rubber stopper + 10 mL Ampoule diluent (in a box) | Rx | Utopian Co., Ltd.Thailand | JustRight Healthcare Inc. | DR-XY32789 | Dec 19, 2029 | |
PrimucefCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection Box of 1's | Rx | Brawn Laboratories Ltd.India | Primus Medicus Distributors Inc.Importer: Ambica International Corporation | DRP-4474-04 | Jun 13, 2028 | |
ProstriazCeftriaxone (as sodium) | 1 g Powder for Inejction (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection Box of 1's | Rx | Brawn Laboratories Ltd.India | Prodrom Nutritionals, IncorporatedImporter: Ambica International Corporation | DRP-4474-12 | Jun 13, 2028 | |
ProtriaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL Type III glass vial with grey bromobutyl rubber stopper, aluminum seal and blue plastic flip-off cap + 10 mL LDPE ampoule SWFI (diluent) in plastic tray (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Providencia Medica Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-14065-04 | Jun 13, 2028 | |
ProtriaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile water for injection as solvent) (Box of 1's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Providencia Medica Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7138-17 | Mar 31, 2027 | |
PuxenonCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal x 10 mL+ Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection x 10 mL Box of 1’s | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | RSG Pharma TradingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-08 | Nov 20, 2028 | |
Q TaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Type III Clear Colorless Glass Vial x 10 mL (Box of 10’s) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Quad-Gen PharmaceuticalsImporter: AMB HK Enterprises Inc. | DRP-9668-01 | Apr 27, 2031 | |
Q-XoneCeftriaxone (As Sodium) | 1g/Vial Powder For Injection (IM/IV)Type 1 Glass Vial W/ Rubber Stopper & Green Flip Off Aluminum Seal + 10 mL Diluent (Sterile Water For Injection) In Type I Glass Ampoules (Box of 1's) | Rx | Shanxi Shuguang Pharmaceutical Co., Ltd.China | Quad-Gen PharmaceuticalsImporter: Asianmeds, Inc. | DRP-2060-04 | Jul 16, 2027 | |
RacefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Type I glass vial with butyl rubber stopper with aluminum seal and blue flip-off cap + 10 mL Sterile Water for Injection (diluent) in plastic tray. (Box of 1's) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Neo Care Philippines, Inc.Importer: Asianmeds, Inc. | DRP-13416-02 | Feb 27, 2028 | |
RacefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL capacity Type III soda lime glass vial with butyl rubber stopper and aluminium plastic cap + USP Type I borosilicate glass ampoule x 10 mL water for injection as diluent (Box of 1's) | Rx | NCPC Hebei Huamin Phamaceutical Company LimitedChina | Neo Care Philippines, Inc.Importer: Euro-Care Products Philippines | DRP-9144-04 | Nov 3, 2031 | |
RacefCeftriaxone (as Sodium) | 1g/vial Powder for Injection (IM/IV)Type I Glass Vial w/ Rubber Stopper & Green Flip Off Aluminum Seal + 10mL Diluent Sterile Water for Injection in Type I Glass Ampoule Box of 1's | Rx | Shanxi Shuguang Pharmaceutical Co., Ltd.China | Neo-Care PhilippinesImporter: Asianmeds, Inc. | DRP-2060-03 | Jul 16, 2027 | |
RainoxoneCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt. Ltd.India | Sanoviz Pharmaceutical Products TradingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-11 | Nov 20, 2028 | |
RetactrimCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type II glass mould vials sealed with gray bromobutyl rubber stopper and blue aluminum plastic cap x 10 mL + clear and transparent USP Type I glass ampoule x 10 mL (net content) Sterile Water for Injection as solvent (Box of 1's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-13685-02 | Mar 28, 2028 | |
RetaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flipoff seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Reta DrugImporter: Greencore Pharma Inc. | DRP-10246-07 | Feb 4, 2032 | |
RetaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP type III clear glass vial with rubber stopper and aluminum blue flip-off seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Reta DrugImporter: Afree Pharmaceutical Distribution Corp. | DRP-14007-04 | Jun 5, 2028 | |
Retaxone-RCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type II glass mould vials sealed with gray bromobutyl rubber stopper and blue aluminum plastic cap x 10 mL + clear and transparent aluminum plastic cap x 10 mL + clear and transparent USP Type I glass ampoule x 10 mL (net content) Sterile Water for Injection as solvent (Box of 1's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-13685-04 | Mar 28, 2028 | |
RetrokorCeftriaxone | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Colorless Glass Vial Box of 1's | Rx | Korea United Pharm., Inc.Korea | One Pharma Marketing Inc. | DR-XY29262 | Dec 18, 2028 | |
RexoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Each box contains: 1 USP Type 1 Clear, Transparent Class Vial with pink flip-off seal (active drug) and 1 10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Rexmed Pharmaceutical SalesImporter: Pharmakon Biotec Inc. | DRP-5240-22 | Apr 7, 2029 | |
ReytriCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Type II Clear Glass Vial with Gray Bromobutyl Rubber Stopper and Blue Aluminum Plastic Cup x 1's (Box of 1's and 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | AMB HK ENTERPRISES INC. | DRP-10928 | Dec 17, 2031 | |
RobixoneCeftriaxone (as sodium) | 1g Powder for Injection (I.M./I.V.)Type III Colorless Glass Vial (1) + 10ml Ampoule (Sterile Water for Injection) NA | Rx | Inject Care Parenterals Pvt. Ltd.India | Rx Global Sales and Mktg. Corp.Importer: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1140-05 | Jan 25, 2032 | |
RocemedCeftriaxone (as sodium) | 1 g Powder for Injection (IV/IM)10 mL-capacity soda lime glass vial with halogenated butyl rubber stopper and aluminum plastic cap (Box of l’s) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Eurocare Products Philippines | DRP-12101 | Jun 13, 2027 | |
RocephinCeftriaxone (as sodium) | 1 g Powder for Injection (IV)Type I Clear Glass Vial with Rubber Stopper and Grey Plastic Flip-off Seal + 10 mL Glass Ampoule (Water for Injection) (Box of 1’s) | Rx | F. Hoffmann-La Roche Ltd.Switzerland | ROCHE (PHILIPPINES) INC. | DR-XY1040 | Jan 26, 2029 | |
RockxionCeftriaxone (as sodium) | 1 g Powder For Injection10 mL USP Type III clear and colourless glass vial with grey bromo butyl rubber stopper and aluminum flip off seal + 10 mL transluscent plastic ampoule (Sterile water for injection) (Box of 1 Vial + 1 Diluent) | Rx | Swiss Parenterals Ltd.India | Redrocks Pharma and Medical Supplies DistributionImporter: Aglobal Care, Inc. | DRP-16534-01 | May 28, 2030 | |
RoxonCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)15 mL USP Type III Clear Glass Vial + Diluent: 10 mL Sterile Water for injection (Box of 1 vial + diluent) | Rx | Karnataka Antibiotics & Pharma LimitedIndia | Phil. Pharmawealth, Inc. | DR-XY27286 | Feb 8, 2027 | |
RoxonCeftriaxone (as Sodium) | 250 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial + Diluent x 10mL (Box of 1's) | Rx | Karnataka Antibiotics & Pharmaceuticals LimitedIndia | Phil. Pharmawealth, Inc. | DR-XY27283 | Feb 7, 2027 | |
SamjizonCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Colorless Type I Glass Vial (Box of 10’s) | Rx | Samjin Pharmaceutical Co., Ltd.Republic of Korea | Unimex, Inc. | DRP-4203 | May 26, 2027 | |
Sanaxone-1000Ceftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)USP Type III Clear and Colorless Glass Vial with rubber stopper, aluminum seal and blue flip-off cap (Box of 1's) | Rx | Sance Laboratories Pvt. Ltd.India | AMB HK ENTERPRISES INC. | DRP-6552 | Mar 7, 2031 | |
SantezonCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Box of 1 - Soda lime glass vial with halogenated rubber stopper and aluminum-plastic flip-off seal + USP Type I Glass Ampoule x 10 mL Water for Injection (Diluent) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Santerra TradingImporter: Euro-Care Products Philippines | DRP-10961-05 | Dec 22, 2026 | |
SantezonCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL capacity Type III soda lime glass vial with butyl rubber stopper and aluminum plastic cap + USP Type I borosilicate glass ampoule x 10 mL water for injection as diluent (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Santerra TradingImporter: Euro-Care Products Philippines | DRP-9144-05 | Nov 3, 2030 | |
SaphtriaxoneCeftriaxone (As Sodium) | 1g Powder For Injection (IM/IV)10 mL-capacity USP Type I clear colourless glass vial, with grey bromo butyl rubber plug and sealed with dark pink coloured flip off aluminium seal (Box of 1's) | Rx | Kilitch Drugs (India) Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-12306 | Jul 12, 2027 | |
SeracefCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories Ltd.India | GX International, Inc.Importer: Ambica International Corporation | DRP-4474-01 | Jun 13, 2028 | |
SerixonCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type 1 Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) (Box of 1 Vial & 1 Diluent) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Curasave PharmaImporter: Pharmakon Biotec Inc. | DRP-5240-21 | Apr 7, 2029 | |
SetrionCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP Type III clear glass vial with grey butyl rubber stopper, aluminum seal and white flip-off cap (Box of 1's) | Rx | Vellinton HealthcareIndia | Pranish Inc | DR-XY49377 | Apr 15, 2030 | |
ShaltraxCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile Water for Injection as solvent) [Box of 1's] | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Shalaks Pharmaceuticals, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7138-02 | Mar 31, 2027 | |
SITIAXONECeftriaxone Sodium | 1 g Powder for Injection (I.M./I.V.)1 g USP Type I Clear Glass Vial with Rubber Stopper and Red Flip-Off Seal + 10 mL Ampoule (Diluent) (Box of 1's) | Rx | Bosch Pharmaceutical (Pvt.) Ltd.Pakistan | Sahar International Trading Inc. | DRP-13818 | Oct 2, 2028 | |
SitixonCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type I Glass Vial with Green Colored Flip-off Seal + 10 mL Water for Injection USP Type I Clear Colorless Glass Ampoule (Box of 1's) | Rx | Zhuhai Kinhoo Pharmaceutical Co., Ltd.China | Sahar International Trading, Inc. | DRP-5929 | Sep 30, 2028 | |
StarcefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)USP Type III Clear Glass Vial with Rubber Stopper and White Flip-off Seal + 10 mL Diluent in Glass Ampoule (Sterile Water for Injection) (Box of 1's) | Rx | Zazen Pharma Pvt. Ltd.India | Medethix, Inc.Importer: I.E. Medica, Inc.Trader: Stratgen Healthcare Pvt. Ltd. | DRP-3715-08 | Sep 28, 2028 | |
StopiraxCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)20 mL Type III round clear glass vial with red rubber stopper enclosed with aluminum cap + 10 mL Type I clear glass ampoule Sterile Water for Injection diluent | Rx | M&H Manufacturing Co., Ltd.Thailand | GPC Geo Pharma Corporation. | DRP-15143 | May 13, 2029 | |
StriaxonCeftriaxone(As Sodium) | 1 g Powder for Injection (IM/IV)USP Type III clear colorless glass vial with bromo butyl rubber stopper and aluminum plastic cap (Box of 10's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Golden Life Pharmaceutical Product DistributionTrader: Salubris Biotherapeutics Limited | DRP-13218 | Jan 3, 2028 | |
Suritricef-1000Ceftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP Type III Flint Glass Vial with Grey Butyl Rubber Stopper and Red Colored Flip Off Seal (Box of 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Pharma-Surrey International, Inc. | DRP-11294 | Nov 22, 2031 | |
SwixoCeftriaxone (as sodium) | 1 g Powder for Injection10 mL USP Type III clear and colourless glass vial with grey bromo butyl rubber stopper and aluminium flip off seal 10 mL translucent plastic ampoule (Sterile water for injection) [Box of 1's] | Rx | Swiss Parenterals Ltd.India | Aglobal Care, Inc. | DRP-16534 | May 28, 2030 | |
SynoxonCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Type III Clear Colorless Glass Vial x 10 mL (Box of 10's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | AMB HK Enterprises Inc. | DRP-9668 | Apr 27, 2031 | |
TamixoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.V./I.M.)10 mL-Capacity USP Type III Flint Glass Vial with Grey Butyl Rubber Stopper and Red aluminum Flip-Off Seal (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Tamiga Pharmaceuticals SupplyImporter: Medinova Pharmaceutical Inc. | DRP-10960-03 | Dec 22, 2026 | |
TGXoneCeftriaxone (as sodium) | 1g Powder for Injection (IM/IV)10 mL-capacity USP type II glass vial with gray bromobutyl rubber stopper and blue aluminum plastic cap (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | TGIF Pharmaceutical Trading Inc.Importer: Dreamax Incorporated | DRP-11898-02 | May 18, 2027 | |
TirifexCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection (Box of 1's) | Rx | Brawn Laboratories LimitedIndia | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-4474-11 | Jun 13, 2028 | |
Tria-GCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip-Off Seal (Box of 10’s) | Rx | Yungjin Pharm. Co., Ltd.Republic of Korea | GPC Geo Pharma CorporationImporter: Unimex, Inc. | DRP-2137-05 | Aug 2, 2029 | |
TriacefCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10-mL transparent and colorless USP type II glass vial sealed with gray bromobutyl rubber stopper and blue aluminum-plastic flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Philgen Pharmaceuticals Inc | DRP-15149 | May 14, 2029 | |
TriaforeCeftriaxone (as Sodium) | 1 g Powder For Injection (IM/IV)USP Type I Clear Glass Vial with Red Flip-Off Seal and Gray Butyl Rubber Stopper + 10 ml Diluent (Box of 1's) | Rx | Phil Inter Pharma Co., Ltd. (Plant 2)Vietnam | Checktrade Pharma, Inc.Importer: Largen Med Inc. | DRP-5461-05 | Aug 18, 2029 | |
TriagenCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./ I.V.)USP Type I Clear Colorless Glass Vial (Box of 10's) | Rx | Phil Inter Pharma Co., Ltd. (Plant 2)Vietnam | Largen Med Inc. | DRP-4718 | Nov 8, 2027 | |
TriamaxCeftriaxone (as sodium) | 1 g Powder for Injection10 mL capacity USP Type II glass vial with rubber stopper and alu-plastic cap (Box of 10's) p (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Incorporated | DRP-15551 | Jul 31, 2029 | |
Triamax-1000Ceftriaxone (As Sodium) | 1g Powder For Injection (IM/IV)10 mL-capacity USP type II glass vial with gray bromobutyl rubber stopper and blue aluminum plastic cap (Box of 1’s) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Incorporated | DRP-11898 | May 18, 2027 | |
TriamedCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Colorless Transparent Borosilicate Glass Vial (Box of 10's and Box of 1's with Diluent) | Rx | Hankook Korus Pharm. Co., Ltd.Republic of Korea | MG Prime Pharmaceutical, Inc. | DR-XY44131 | Feb 2, 2030 | |
TriamedCeftriaxone(as Sodium) | 1g Powder for Injection (IM/IV)Type I Glass Colorless Borosilicate Vial With Flip-off Cap (Box of 10’s) | Rx | Shin Poong Pharm Co., Ltd.Republic of Korea | MG Prime Pharmaceutical, Inc.Importer: Phil. Shinpoong Pharma Inc. | DRP-290-07 | Apr 11, 2031 | |
TriascefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL- capacity USP Type III Molded Clear Glass Vial w/ grey bromo butyl rubber stopper and dark blue flipoff seal + LDPE Plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | JPMR PharmaImporter: Greencore Pharma Inc. | DRP-10246-06 | Feb 8, 2032 | |
TriasenzCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Type I Glass Vial (Box of 10's) | Rx | Kyung Dong Pharm Co., Ltd.Republic of Korea | Pharmakon Pharmaceutical Inc.Importer: H & B Pharma International Inc. | DRP-5834-03 | Sep 12, 2028 | |
Triavex 1Ceftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)10 mL Borosilicate Vial + 10 mL Sterile Water for Injection (Box of 1 Vial + Diluent) | Rx | NORTH CHINA PHARMACEUTICAL CO., LTDChina | SANNOVEX PHARMACEUTICAL DISTRIBUTOR | DRP-4867 | Oct 24, 2028 | |
TriaxCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL-capacity USP Type III clear and colorless glass vial with 10 mL translucent plastic ampoule (containing Sterile Water for Injection as diluent) in white PVC tray (Box of 1's) | Rx | Swiss Parenterals Ltd. (Block-B)India | Aglobal Care, Inc. | DR-XY45746 | Jan 17, 2027 | |
TriaxCeftriaxone (as sodium) | 1g Powder for Injection (IM/IV)10 mL-capacity USP type II glass vial with gray bromobutyl rubber stopper and blue aluminum plastic cap. (Box of 1's with Diluent) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Basic Pharmaceutical CorporationImporter: Dreamax Incorporated | DRP-11898-06 | May 18, 2027 | |
Triax-1Ceftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip-Off Seal (Box of 10’s) | Rx | YUNGJIN PHARMACEUTICAL CO., LTD.Republic of Korea | Basic Pharmaceutical CorporationImporter: UNIMEX, INC. | DRP-2137-01 | Aug 2, 2029 | |
Triax-1Ceftriaxone (As Sodium) | 1g Powder For Injection (IM/IV)USP Type I clear glass vial with red flip-off seal and gray butyl rubber stopper + 10mL diluent (Box of 1's) | Rx | Phil Inter Pharma Co., Ltd.Vietnam | Basic Pharmaceutical CorporationImporter: Largen Med, Inc. | DRP-5461-03 | Aug 28, 2029 | |
TriaxcefCeftriaxone (as Sodium) | 1g Powder for Injection (IM/IV)10 mL-capacity USP Type II Glass Vial with Gray Bromobutyl Rubber Stopper and Blue Aluminum Plastic Cap (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Life Sciences IncorporatedImporter: Dreamax Incorporated | DRP-11898-01 | May 18, 2027 | |
TriaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip-Off Seal Box of 10’s | Rx | YUNGJIN PHARMACEUTICAL CO., LTD.Republic of Korea | UNITED PHARMA PLUS (UNIPHARMA), INC.Importer: UNIMEX, INC. | DRP-2137-03 | Aug 2, 2029 | |
TriaxoneCeftriaxone (as Sodium) | 1g Powder for Injection (IM/IV)10mL-capacity Type I Colorless and transparent glass vial with dark gray rubber closure and blue aluminum cap x 1's (Box of 10's) | Rx | Union Korea Pharm Co.,Ltd.Republic of Korea | United Pharma Plus (UNIPHARMA) INC.Importer: JLT Pharma Inc | DRP-9065-03 | Dec 1, 2027 | |
TriaxsaveCeftriaxone (as sodium) | 1 g Powder for Injection10 mL USP Type III clear and colorless glass vial with grey bromo butyl rubber stopper and aluminum flip-off seal + 10 mL translucent plastic ampoule (Sterile Water for Injection) [Box of 1's] | Rx | Swiss Parenterals Ltd.India | CureSave PharmaImporter: Aglobal Care, Inc. | DRP-16534-05 | May 28, 2030 | |
TriaxseaCeftriaxone (as sodium) | 1g Powder for Injection (IV/IM)USP Type III clear and colorless glass vial with red flip-off seal Box of 1's and 10's | Rx | YELURI FORMULATIONS PVT. LTD.India | SEA-KING PHARMA INC.Importer: GROVIC PHARMA INC. | DRP-3815-03 | Jun 28, 2029 | |
TriaxsheenCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type I Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type I Clear, Transparent Ampoule (Diluent: Sterile Water for Injection) (Box of 1's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Farmacia SheenaImporter: Pharmakon Biotec, Inc. | DRP-5240-29 | Apr 7, 2029 | |
TriaxteenCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial (Box of 1's) | Rx | Gnana Life Sciences Pvt. Ltd.India | Trisixteen Pharmaceutical Products TradingImporter: Ambica International Corporation | DRP-4186-01 | Jan 28, 2028 | |
TriazoneCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Colorless Glass Vial (Box of 10's) | Rx | Phil Inter Pharma Co., Ltd. (Plant 2)Vietnam | Pharma King DistributorImporter: Largen Med Inc. | DRP-4718-01 | Nov 8, 2027 | |
TricexoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL-capacity USP Type I clear colourless glass vial, with grey bromo butyl rubber plug and sealed with dark pink coloured filp off aluminum seal + Sterile Water for Injection in Clear Glass Ampoule x 10 mL (Box of 1's) | Rx | Kilitch Drugs (India) Ltd.India | ECE Pharmaceuticals, Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-12306-02 | Jul 12, 2027 | |
TricexoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL Type III glass vial with grey bromobutyl rubber stopper, aluminum seal and blue plastic flip-off cap + 10 mL LDPE ampoule SWFI (diluent) in plastic tray (Box of 1's) | Rx | Swiss Parenterals Inc.India | ECE Pharmaceuticals Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-14065-01 | Jun 13, 2028 | |
TricexoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile Water for Injection as solvent) [Box of 1's] | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | ECE Pharmaceuticals, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7138-08 | Mar 31, 2027 | |
TrimaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP type II glass vial with gray bromobutyl rubber stopper and blue aluminum plastic cap (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Life Sciences IncorporatedImporter: Dreamax Incorporated | DRP-11898-03 | May 18, 2027 | |
TriophinCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP Type I clear and colorless glass vial with grey bromobutyl rubber stopper and blue aluminum flip-off cap (Box of 10's) | Rx | Shenzhen China Resources Gosun Pharmaceuticals Co., Ltd.China | Raquel Abbas Pharma Inc. | DRP-17748 | Feb 26, 2031 | |
TrioxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type 1 Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) (Box of 1 Vial & 1 Diluent) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Sincera Pharmaceutical Corp.Importer: Pharmakon Biotec Inc. | DRP-5240-01 | Apr 7, 2029 | |
TriservCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal + 10 mL plastic ampoule (Sterile water for injection as solvent) [Box of 1's] | Rx | Zeiss Pharmaceuticals, Pvt. Ltd.India | Truserve Pharmaceutical DistributorImporter: Sanimed Pharmaceuticals Inc. | DRP-7138-09 | Mar 31, 2027 | |
TrixcefCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type III clear glass vial with rubber stopper and white flip-off seal + I0 mL Diluent in glass ampoule (Sterile Water for Injection) Box of 1 's | Rx | Zazen Pharma Pvt. Ltd.India | I.E. Medica, Inc.Trader: Stratgen Heathcare Pvt. Ltd. | DRP-3715 | Sep 28, 2028 | |
TrixchelCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Clear Glass Vial + 10 mL Glass Ampoule of Sterile Water for Injection Box of 1's | Rx | Brawn Laboratories Ltd.India | Ixchel Pharmaceutical Distribution, Inc.Importer: Ambica International Corporation | DRP-4474-05 | Jun 13, 2028 | |
TrixophinCeftriaxone | 1 g Powder for Injection (IV/IM)15 mL Capacity Borosilicate Tube Clear Glass Vial with Butyl Rubber Stopper and Aluminum Red Plastic Flip-off Cap, 1 Vial per Individual Box (Box of 10's) | Rx | Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., LtdChina | Dynasty Pharmaceuticals | DRP-8488 | Mar 25, 2031 | |
Trixophin-WCeftriaxone (as sodium) | 1 g Sterile Powder for Solution for Injection (IM/IV)10 mL Low Borosilicate Glass Vial with Halogenated Butyl Rubber Stopper and Capped with Aluminum Plastic Cap (Box of 1's and 10's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Dynasty Pharmaceuticals | DR-XY49085 | May 17, 2029 | |
Trixophin-WCeftriaxone (as sodium) | 1 g Sterile Powder for Solution for Injection (IM/IV)10 mL Low Borosilicate Glass Vial with Halogenated Butyl Rubber Stopper and Capped with Aluminum Plastic Cap (Box of 1's and 10's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Dynasty Pharmaceuticals | DRP-15281 | May 17, 2029 | |
TrixsurCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)12 mL-capacity type II clear glass vial with bromobutyl rubber stopper and yellow alu-plastic cap ( Box of 1's) | Rx | Zhuhai United Laboratories (Zhongshan) Co., Ltd.China | Pharma-Surrey International, Inc. | DRP-12350 | Jul 22, 2027 | |
TrizetoCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type 1 Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) (Box of 1 Vial & 1 Diluent) | Rx | SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATION LIMITEDIndia | Sonchel Pharma DistributorsImporter: Pharmakon Biotec Inc. | DRP-5240-12 | Apr 7, 2029 | |
TrizonCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL Type III glass vial with grey bromobutyl rubber stopper, aluminum seal and blue plastic flip-off cap + 10 mL LDPE ampoule SWFI (diluent) in plastic tray (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Nutramedica Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-14065-06 | Jun 13, 2028 | |
TrizonCeftriaxone (as sodium) | 1g Powder for Injection (I.M./I.V.)USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and blue flip-off seal x 10mL + Plastic ampoule (Sterile Water for Injection as solvent) x 10 mL Box of 1's | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Nutramedica Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7138-03 | Mar 31, 2027 | |
TrizoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Type I clear, colorless glass vial with rubber stopper and blue flip off seal x 1g (Box of 1's; Box of 50's) | Rx | Taiwan Biotech Co. Ltd.China | Nutramedica Inc.Importer: Neo-Care PhilippinesTrader: Kwanstar Co.,Ltd. | DRP-3009-03 | Aug 11, 2027 | |
TronCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial with Gray Butyl Rubber Closure and Sealed with Aluminum Cap and Red Flip-off Plastic Cap x 25 mL (Box of 10’s) | Rx | Chong Kun Dang Pharmaceutical Co., LtdRepublic of Korea | Unimex, Inc. | DRP-7840 | Apr 4, 2031 | |
TY-OxoneCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)USP Type I Clear & Colorless Glass Vial + 5 mL Water for Injection in Clear Glass Ampoule (In a box) | Rx | Geofman PharmaceuticalsPakistan | Sahar International Trading Inc. | DRP-1280 | Jan 15, 2027 | |
TY-OxoneCeftriaxone (as Sodium) | 250 mg Powder for Injection (I.M./I.V.)USP Type I Clear & Colorless Glass Vial + Water for Injection 5 mL Clear Glass Ampoule (Individually Boxed) | Rx | Geofman PharmaceuticalsPakistan | Sahar International Trading Inc. | DRP-1279 | Jan 15, 2027 | |
TY-OxoneCeftriaxone (as Sodium) | 500 mg Powder for Injection (I.M./I.V.)USP Type I Clear & Colorless Glass Vial + Water for Injection 5 mL Clear Glass Ampoule (Individually Boxed) | Rx | Geofman PharmaceuticalsPakistan | Sahar International Trading Inc. | DRP-1298 | Jan 15, 2027 | |
UcefCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)1 USP Type 1 Clear, Transparent Glass Vial with pink flip-off seal (active drug) and 1-10 mL USP Type 1 Clear, Transparent ampoule (diluent: Sterile Water for Injection) (Box of 1 Vial & 1 Diluent) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Universal MBF Pharma (UMP), Co.Importer: Pharmakon Biotec Inc. | DRP-5240-04 | Apr 7, 2029 | |
UnitiaxoneCeftriaxone (As Sodium) | 1g Powder For Injection (IM/IV)10 mL-capacity Type I Colorless and transparent glass vial with dark gray rubber closure and blue aluminium cap x 1's (Box of 10's) | Rx | Union Korea Pharm Co., Ltd.Korea | JLT Pharma, Inc. | DRP-9065 | Dec 1, 2027 | |
UnitiaxoneCeftriaxone (as Sodium) | 2g Powder for Injection (IM/IV)USP Type I Borosilicate Glass Vial (Box of 10's) | Rx | Union Korea Pharm Co., Ltd.Korea | JLT Pharma Inc. | DRP-11115 | Feb 3, 2027 | |
UnixoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip-Off Seal (Box of 10’s) | Rx | YUNGJIN PHARM. CO., LTD.Republic of Korea | UNIMEX, INC. | DRP-2137 | Aug 2, 2029 | |
ValcetraxCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)Type I Glass Colorless Borosilicate Vial With Flip-off Cap (Box of 10’s) | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | EMRU TradingImporter: PHIL. SHINPOONG PHARMA INC. | DRP-290-02 | Dec 12, 2031 | |
ValtriaxCeftriaxone Sodium | 1 g Powder for Injection (IM/IV)Individually Boxed USP Type I Borosilicate Glass Vial with Blue Flip-off Seal x 10 ml diluent Sterile Water for Injection (BP) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., LtdChina | SwissPharmatech Co.Importer: AMB HK Enterprises Inc. | DRP-3601-11 | Feb 14, 2029 | |
VexonCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)Individually Boxed Type II Clear and Colorless Glass Vial with Pink Flip-off Seal x 1 g (Box of 10's)) (Box of 10's) | Rx | Shandong Xier Kangtai Pharmaceutical Co., LtdChina | Sannovex Pharmaceutical Distributor | DRP-2507 | Apr 6, 2031 | |
VextriaCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type III Colorless Glass Vial (1) + 10 ml Ampoule (Sterile Water for Injection) Box of 1's | Rx | Inject Care Parenterals Pvt. Ltd.India | Medirich Pharma Distribution Corp.Importer: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1140-10 | Dec 8, 2031 | |
ViatrexCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip-Off Seal (Box of 10’s) | Rx | YUNGJIN PHARMACEUTICAL CO., LTD.Republic of Korea | BELL-KENZ PHARMA INC.Importer: UNIMEX, INC. | DRP-2137-04 | Aug 2, 2029 | |
VicaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Flint Glass Vial packed in individual box (Box of 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Multigro Healthcare Inc.Importer: Grovic Pharma Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-5951-01 | Jan 23, 2030 | |
ViptriaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)In a 10 mL-capacity USP Type III molded clear glass vial w/ grey bromo butyl rubber stopper and dark blue flip-off seal + LDPE plastic ampoule x 10 mL - diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Vios Integrated Projects (Vip) Inc.Importer: Greencore Pharma Inc. | DRP-10246-12 | Feb 8, 2032 | |
WestriaxoneCeftriaxone (As Sodium) | 1g/Vial Powder For Injection (IM/IV)Type I Glass Vial W/ Rubber Stopper & Green Flip Off Aluminum Seal + 10 mL Diluent (Sterile Water For Injection) In Type I Glass Ampoules (Box of 1's) | Rx | Shanxi Shuguang Pharmaceutical Co., Ltd.China | Westwing Pharma Sales, Inc.Importer: Asianmeds, Inc. | DRP-2060-05 | Jul 16, 2027 | |
XiaxCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M./I.V.)USP Type I Clear Colorless Glass Vial (Box of 10's) | Rx | Phil Inter Pharma Co., Ltd. (Plant 2)Vietnam | All-Bio Pharma, Inc.Importer: Largen Med Inc. | DRP-4718-02 | Nov 8, 2027 | |
XiaxoneCeftriaxone (as sodium) | 1 g Powder for Injection (IV)10 mL-capacity USP type II glass vial with rubber stopper and alu-plastic cap (Box of 10’s) | Rx | Reyoung Pharmaceutical Co., Ltd.China | CV Clearvue Pharma, Inc.Importer: Dreamax Incorporated | DRP-15551-01 | Jul 31, 2029 | |
XonemedCeftriaxone sodium | 1 g Powder for Injection (IM/IV)Low borosilicate tubular glass vial, sealed with halogenated butyl rubber stopper, capped with aluminum-plastics combination caps x 10 mL (Box of 10’s) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Dreamax Incorporated | DRP-18619 | Aug 11, 2031 | |
XonetCeftriaxone (as sodium) | 1 g Powder for Injection (I.V./I.M.)10 mL-Capacity USP Type III Flint Glass Vial with Grey Butyl Rubber Stopper and Red Aluminum Flip-Off Seal (Box of 1's and 10's) | Rx | Yeluri Formulations Pvt Ltd.India | Guimhealth Pharmaceutical Distributor And DrugstoreImporter: Medinova Pharmaceutical Inc. | DRP-10960-04 | Dec 22, 2026 | |
XtendaCeftriaxone (as sodium) | 1 g per vial Powder for Injection (IM/IV)USP Type I Glass Vial with Aluminum Seal, Rubber Stopper & Blue Colored Protective Cap + Diluent x 10 mL (Box of 1's) | Rx | Elfin Drugs Pvt., Ltd.India | Pharmasia- Cuvest IncorporatedImporter: Divjot Enterprises Corp. | DRP-5799-01 | Dec 13, 2028 | |
XtendaCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)BP Type I Colorless Glass Vial x 1's + LDPE Ampoule x 10 mL (diluent) (Box of 1's) | Rx | Samchundang Pharm., Co., Ltd.Republic of Korea | PharmAsia-Cuvest Incorporated | DR-XY40686 | Feb 27, 2027 | |
Z-xoneCeftriaxone (as sodium) | 1g Powder for Inejction (IM/IV)USP Type III flint glass vial with grey butyl rubber stopper and flip-off seal x 10mL (Box of 1's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Biocare Lifesciences, Inc. | DRP-7856 | May 17, 2028 | |
Zainox 1GCeftriaxone (as Sodium) | 1g Powder for Injection (IM/IV)10 mL-capacity Type I Colorless and transparent glass vial with dark gray rubber closure and blue aluminum cap x 1's (Box of 10's) | Rx | Union Korea Pharm Co., Ltd.Korea | Speed Cure PharmaImporter: JLT Pharma Inc. | DRP-9065-01 | Dec 1, 2027 | |
ZefprojinCeftriaxone (as Sodium) | 1 g Powder for Solution Injection10 mL Type III moulded glass vial with grey butyl rubber stopper, sealed with a blue colour flip off Aluminum Seal | Rx | Innova CaptabIndia | Ambica International Corporation | DRP-16767 | Jul 9, 2030 | |
ZefraxCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)Type I clear, colorless glass vial with rubber stopper and blue flip off seal x 1g (Box of l's; Box of 50's) | Rx | Taiwan Biotech Co. Ltd.China | Neo-Care PhilippinesImporter: Kwanstar Pharma DistributorTrader: Kwanstar Co.,Ltd, | DRP-3009 | Aug 11, 2027 | |
ZeftinoxCeftriaxone (as sodium) | 1 g Powder for Solution for Injection (IV/IM)Middle Borosilicate Glass Vial with Rubber Stopper and Flip-Off Cap x 15 mL + Water for Injection in Low Borosilicate Glass Ampoule x 10 mL (Box of 1 vial and 1 ampoule) | Rx | Chengdu Brilliant Pharmaceutical Co., Ltd.China | Zienac Pharmaceutical Trading. | DR-XY49091 | May 23, 2029 | |
ZeftralCeftriaxone Sodium | 1 g Powder for Injection (I.M./I.V.)1 g USP Type I Clear Glass Vial with Rubber Stopper and Red Flip-Off Seal + 10 mL Ampoule (Diluent) (Box of 1's) | Rx | Bosch Pharmaceuticals (Pvt.) Ltd.Pakistan | Jalmedbase Pharna Corp.Importer: Sahar International Trading Inc. | DRP-13818-02 | Oct 2, 2028 | |
Zeftri 1Ceftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL-capacity USP Type II clear and colorless glass vial sealed with grey bromobutyl rubber stopper and aluminum seal with blue plastic flip-off cap + 10 mL Sterile Water for Injection in USP Type I clear and colorless glass ampoule (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Zion Pharmaceutical Product DistributionImporter: GPC Geo Pharma Corporation | DRP-13950-02 | May 24, 2028 | |
ZeftrimaxCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity USP type II glass vial with gray bromobutyl rubber stopper and blue aluminum plastic cap (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Life Sciences IncorporatedImporter: Dreamax Incorporated | DRP-11898-04 | May 18, 2027 | |
ZentriaxoneCeftriaxone (as Sodium) | 1 g Powder for Injection (I.M/I.V)USP Type III 10 mL Vial with flip-off orange-colored seal x 1's (Box of 1's) | Rx | Innova Captab LimitedIndia | JWK Enterprises, Inc.Importer: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-3242-01 | Feb 8, 2028 | |
ZeptriCeftriaxone (as sodium) | 1 g Powder for InjectionBP Type I colorless glass vial (Box of 10' s) | Rx | Myungmoon Pharmaceutical Co., Ltd.Republic of Korea | Zyre Pharmaceuticals Corporation | DRP-7293 | Dec 3, 2028 | |
ZeptriagemCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL capacity Type III soda lime glass vial with butyl rubber stopper and aluminium plastic cap + USP Type I borosilicate glass ampoule x 10 mL water for injection as diluent (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Euro-Care Products Philippines | DRP-9144 | Nov 3, 2030 | |
ZeptriaveeCeftriaxone (as sodium) | 1 g Powder for Injection (IM/IV)10 mL-capacity Type III soda lime glass vial with butyl rubber stopper and aluminium plastic cap + USP Type I Borosilicate Glass Ampoule x 10 mL Water for Injection as Diluent (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Asianmeds, Inc.Importer: Euro-Care Products Philippines | DRP-9144-01 | Sep 19, 2031 | |
ZeptrickCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)Type I glass vial with butyl rubber stopper with aluminum seal and blue flip-off cap + 10 mL Sterile Water for Injection (diluent) in plastic tray (Box of 1's) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Asianmeds, Inc. | DRP-13416 | Feb 27, 2028 | |
ZeroneCeftriaxone (as Sodium) | 1 g Powder for Injection (IM/IV)Type III Colorless Glass Vial (1) + 10 mL Ampoule (Sterile Water for Injection) | Rx | Inject Care Parenterals Pvt. Ltd.India | Vintel Med EnterprisesImporter: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1140 | Feb 19, 2031 | |
ZonetriacCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./ I.V.)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Detoxicare Phils., Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-19 | Nov 20, 2028 | |
ZonetriacCeftriaxone (as sodium) | 1 g Powder for Injection (I.M./I.V.)10 mL USP Type III Colorless Flint Glass Vial with Grey Butyl Rubber Stopper and Green Flip-off Aluminum Seal + 10 mL Clear Colorless Form Fill Seal (FFS) Ampoule Sterile Water for Injection (Box of 1’s) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Detoxicare Phils., Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4940-20 | Nov 20, 2028 | |
(no brand name)Ceftriaxone (As Sodium) | 1 g Powder For Injection (I.M./I.V)10 mL USP Type III clear glass vial with grey bromo butyl rubber stopper and flip-off orange-coloured aluminium seal x 1's (Box of 1's) | Rx | Innova Captab LimitedIndia | Speed Cure PharmaImporter: Ambica International CorporationTrader: Virchow Healthcare Private Limited | DRP-3242 | Feb 8, 2028 | |
(no brand name)Ceftriaxone (As Sodium) | 1 g Powder For Injection (IM/IV)10 mL-capacity USP Type II glass vial with gray bromobutyl rubber stopper and blue aluminum plastic cap (Box of 1 x 10 individual box) | Rx | Reyoung Pharmaceutical Co., Ltd.China | First Global Trading CorporationTrader: Liforce Industrial Co., Ltd. | DR-XY48081 | Jun 2, 2027 | |
(no brand name)Ceftriaxone (as Sodium) | 1g Powder for Injection (IM/IV)100 mL-capacity Type III clear glass vial with butyl rubber stopper and aluminum flip-off cap (Box of 10 vials) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Kwanstar Pharma Distributor | DRP-12618 | Sep 21, 2027 | |
1g Powder for Injection (IV Infusion)Polyethylene bag consisting of the powder bag (drug product) and 100 mL diluent bag (isotonic sodium chloride solution) | Rx | Nipro Pharma Corporation Odate PlantJapan | Onesource Pharma Solutions, Inc. | DR-XY47647 | Jan 7, 2027 | ||
(no brand name)Ceftriaxone (as sodium) | 2 g Powder For Injection (IM/IV)20 mL-capacity USP Type III Clear Glass Vial with rubber stopper and aluminum grey flip-off seal (Box of 1's) | Rx | Vellinton HealthcareIndia | Pranish Inc. | DR-XY48950 | Dec 20, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
WARNINGS Hypersensitivity Reactions Before therapy with ceftriaxone is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to cephalosporins, penicillins and other beta-lactam agents or other drugs. This product should be given cautiously to penicillin and other beta-lactam agent‑sensitive patients.
Antibacterial drugs should be administered with caution to any patient who has demonstrated some form of allergy, particularly to drugs. Serious acute hypersensitivity reactions may require the use of subcutaneous epinephrine and other emergency measures. As with all beta-lactam antibacterial agents, serious and occasionally fatal hypersensitivity reactions (i.e., anaphylaxis) have been reported.
In case of severe hypersensitivity reactions, treatment with ceftriaxone must be discontinued immediately and adequate emergency measures must be initiated. Interaction with Calcium-Containing Products Do not use diluents containing calcium, such as Ringer’s solution or Hartmann’s solution, to reconstitute ceftriaxone vials or to further dilute a reconstituted vial for IV administration because a precipitate can form.
Precipitation of ceftriaxone-calcium can also occur when ceftriaxone is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone must not be administered simultaneously with calcium-containing IV solutions, including continuous calcium-containing infusions such as parenteral nutrition via a Y-site.
However, in patients other than neonates, ceftriaxone and calcium-containing solutions may be administered sequentially of one another if the infusion lines are thoroughly flushed between infusions with a compatible fluid. In vitro studies using adult and neonatal plasma from umbilical cord blood demonstrated that neonates have an increased risk of precipitation of ceftriaxone-calcium (see CLINICAL PHARMACOLOGY, CONTRAINDICATIONS and DOSAGE AND ADMINISTRATION).
Neurological Adverse Reactions Serious neurological adverse reactions have been reported during postmarketing surveillance with ceftriaxone use. These reactions include encephalopathy (disturbance of consciousness including somnolence, lethargy, and confusion), seizures, myoclonus, and non-convulsive status epilepticus (see ADVERSE REACTIONS).
Some cases occurred in patients with severe renal impairment who did not receive appropriate dosage adjustment. However, in other cases, neurological adverse reactions occurred in patients receiving an appropriate dosage adjustment. The neurological adverse reactions were reversible and resolved after discontinuation. If neurological adverse reactions associated with Ceftriaxone for Injection therapy occur, discontinue Ceftriaxone for Injection and institute appropriate supportive measures.
Make appropriate dosage adjustments in patients with severe renal impairment (see DOSAGE AND ADMINISTRATION). Clostridium difficile -Associated Diarrhea Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including ceftriaxone, and may range in severity from mild diarrhea to fatal colitis.
Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile. C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy.
CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued.
Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated. Hemolytic Anemia An immune mediated hemolytic anemia has been observed in patients receiving cephalosporin class antibacterials including ceftriaxone.
Severe cases of hemolytic anemia, including fatalities, have been reported during treatment in both adults and children. If a patient develops anemia while on ceftriaxone, the diagnosis of a cephalosporin associated anemia should be considered and ceftriaxone stopped until the etiology is determined.
Drug interactions
| Drug or class | Severity | Effect | What to do |
|---|---|---|---|
| Calcium-containing IV solutions (Ringer's, Hartmann's, parenteral nutrition) | Avoid | Ceftriaxone-calcium precipitates; fatal lung and kidney deposits in neonates (label). | Never mix or give together; neonates: contraindicated; others: give sequentially with line flushes. |
Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.
renalcarematters.com, reviewedAdverse reactions
Common
- Injection-site pain or induration; phlebitis
- Diarrhea, rash
- Eosinophilia, thrombocytosis, raised liver enzymes
Serious
- Anaphylaxis
- Hemolytic anemia
- Ceftriaxone-calcium precipitation (gallbladder, kidney; lung in neonates)
- Encephalopathy, seizures, nonconvulsive status epilepticus (severe kidney impairment)
- Clostridioides difficile-associated diarrhea
Adverse reactions (US label) US FDA label
ADVERSE REACTIONS Ceftriaxone is generally well tolerated. In clinical trials, the following adverse reactions, which were considered to be related to ceftriaxone therapy or of uncertain etiology, were observed: LOCAL REACTIONS – pain, induration and tenderness was 1% overall. Phlebitis was reported in < 1% after IV administration.
The incidence of warmth, tightness or induration was 17% (3/17) after IM administration of 350 mg/mL and 5% (1/20) after IM administration of 250 mg/mL.
GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS — injection site pain (0.6%). HYPERSENSITIVITY – rash (1.7%). Less frequently reported (< 1%) were pruritus, fever or chills.
INFECTIONS AND INFESTATIONS — genital fungal infection (0.1%). HEMATOLOGIC – eosinophilia (6%), thrombocytosis (5.1%) and leukopenia (2.1%). Less frequently reported (< 1%) were anemia, hemolytic anemia, neutropenia, lymphopenia, thrombocytopenia and prolongation of the prothrombin time.
BLOOD AND LYMPHATIC DISORDERS — granulocytopenia (0.9%), coagulopathy (0.4%). GASTROINTESTINAL – diarrhea/loose stools (2.7%). Less frequently reported (< 1%) were nausea or vomiting, and dysgeusia. The onset of pseudomembranous colitis symptoms may occur during or after antibacterial treatment (see WARNINGS). HEPATIC – elevations of aspartate aminotransferase (AST) (3.1%) or alanine aminotransferase (ALT) (3.3%).
Less frequently reported (< 1%) were elevations of alkaline phosphatase and bilirubin. RENAL – elevations of the BUN (1.2%). Less frequently reported (< 1%) were elevations of creatinine and the presence of casts in the urine. CENTRAL NERVOUS SYSTEM – headache or dizziness were reported occasionally (< 1%). GENITOURINARY – moniliasis or vaginitis were reported occasionally (< 1%).
MISCELLANEOUS – diaphoresis and flushing were reported occasionally (< 1%). INVESTIGATIONS—blood creatinine increased (0.6%). Other rarely observed adverse reactions (< 0.1%) include abdominal pain, agranulocytosis, allergic pneumonitis, anaphylaxis, basophilia, biliary lithiasis, bronchospasm, colitis, dyspepsia, epistaxis, flatulence, gallbladder sludge, glycosuria, hematuria, jaundice, leukocytosis, lymphocytosis, monocytosis, nephrolithiasis, palpitations, a decrease in the prothrombin time, renal precipitations, seizures, and serum sickness.
Post-marketing Experience In addition to the adverse reactions reported during clinical trials, the following adverse experiences have been reported during clinical practice in patients treated with ceftriaxone. Data are generally insufficient to allow an estimate of incidence or to establish causation. A small number of cases of fatal outcomes in which a crystalline material was observed in the lungs and kidneys at autopsy have been reported in neonates receiving ceftriaxone and calcium-containing fluids.
In some of these cases, the same intravenous infusion line was used for both ceftriaxone and calcium‑containing fluids and in some a precipitate was observed in the intravenous infusion line. At least one fatality has been reported in a neonate in whom ceftriaxone and calcium‑containing fluids were administered at different time points via different intravenous lines; no crystalline material was observed at autopsy in this neonate.
There have been no similar reports in patients other than neonates. GASTROINTESTINAL – pancreatitis, stomatitis and glossitis. GENITOURINARY – oliguria, ureteric obstruction, post-renal acute renal failure. DERMATOLOGIC – exanthema, allergic dermatitis, urticaria, edema; acute generalized exanthematous pustulosis (AGEP) and isolated cases of severe cutaneous adverse reactions (erythema multiforme, Stevens-Johnson syndrome or Lyell’s syndrome/toxic epidermal necrolysis) have been reported.
HEMATOLOGICAL CHANGES – isolated cases of agranulocytosis (< 500/mm 3) have been reported, most of them after 10 days of treatment and following total doses of 20 g or more. NEUROLOGIC – encephalopathy, seizures, myoclonus. and non-convulsive status epilepticus (see WARNINGS AND PRECAUTIONS). OTHER, Adverse Reactions – symptomatic precipitation of ceftriaxone calcium salt in the gallbladder, kernicterus, oliguria, and anaphylactic or anaphylactoid reactions.
Cephalosporin Class Adverse Reactions In addition to the adverse reactions listed above which have been observed in patients treated with ceftriaxone, the following adverse reactions and altered laboratory test results have been reported for cephalosporin class antibiotics: Adverse Reactions: Allergic reactions, drug fever, serum sickness-like reaction, renal dysfunction, toxic nephropathy, reversible hyperactivity, hypertonia, hepatic dysfunction including cholestasis, aplastic anemia, hemorrhage, and superinfection. Altered Laboratory Tests: Positive direct Coombs’ test, false-positive test for urinary glucose, and elevated LDH (see PRECAUTIONS).
Several cephalosporins have been implicated in triggering seizures, particularly in patients with renal impairment when the dosage was not reduced (see DOSAGE AND ADMINISTRATION). If seizures associated with drug therapy occur, the drug should be discontinued. Anticonvulsant therapy can be given if clinically indicated. To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-877-845-0689 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Monitoring parameters
- Neurologic status in severe kidney impairment; gallbladder sludge or stones and kidney precipitation (symptomatic ceftriaxone-calcium precipitates); hemolytic anemia; prothrombin time in patients at risk (label). Kidney
- Neurologic status in severe kidney impairment
- Signs of biliary or urinary precipitation
- Hemoglobin if hemolysis suspected
Pregnancy considerations
Pregnancy (US label) US FDA label
Pregnancy Teratogenic Effects Reproductive studies have been performed in mice and rats at doses up to 20 times the usual human dose and have no evidence of embryotoxicity, fetotoxicity or teratogenicity. In primates, no embryotoxicity or teratogenicity was demonstrated at a dose approximately 3 times the human dose. There are, however, no adequate and well-controlled studies in pregnant women.
Because animal reproductive studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Nonteratogenic Effects: In rats, in the Segment I (fertility and general reproduction) and Segment III (perinatal and postnatal) studies with intravenously administered ceftriaxone, no adverse effects were noted on various reproductive parameters during gestation and lactation, including postnatal growth, functional behavior and reproductive ability of the offspring, at doses of 586 mg/kg/day or less.
Breastfeeding considerations
Lactation (US label) US FDA label
Nursing Mothers Low concentrations of ceftriaxone are excreted in human milk. Caution should be exercised when ceftriaxone is administered to a nursing woman.
Mechanism of action
Mechanism of Action Ceftriaxone is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Ceftriaxone has activity in the presence of some beta-lactamases, both penicillinases and cephalosporinases, of Gram-negative and Gram-positive bacteria.
US FDA labelPharmacokinetics
Key PK parameters
| Half-life | 5.8 to 8.7 hours |
|---|---|
| Half-life in kidney failure (ESKD) kidney | About 14.7 hours on hemodialysis; 15.7 hours at CrCl 5–15 (label Table 4) |
| Volume of distribution | 5.8 to 13.5 L |
| Protein binding | 85% to 95% (falls as concentration rises) |
| Metabolism (CYP, transporters) | Not metabolized; biliary portion inactivated in gut |
| Renal excretion kidney | 33% to 67% unchanged in urine; rest in bile |
| Dialyzability kidney | No (label) |
Urinary Concentrations of Ceftriaxone After Single Dose Administration Dose/Route Average Urinary Concentrations (mcg/mL) 0 - 2 hr 2 - 4 hr 4 - 8 hr 8 - 12 hr 12 - 24 hr 24 - 48 hr 0.5 gm IV 526 366 142 87 70 15 0.5 gm IM 115 425 308 127 96 28 1 gm IV 995 855 293 147 132 32 1 gm IM 504 628 418 237 ND ND 2 gm IV 2692 1976 757 274 198 40 ND = Not determined.
Thirty-three percent to 67% of a ceftriaxone dose was excreted in the urine as unchanged drug and the remainder was secreted in the bile and ultimately found in the feces as microbiologically inactive compounds.
Over a 0.15 to 3 gm dose range in healthy adult subjects, the values of elimination half-life ranged from 5.8 to 8.7 hours; apparent volume of distribution from 5.78 to 13.5 L; plasma clearance from 0.58 to 1.45 L/hour; and renal clearance from 0.32 to 0.73 L/hour.
The average values of maximum plasma concentration, elimination half-life, plasma clearance and volume of distribution after a 50 mg/kg IV dose and after a 75 mg/kg IV dose in pediatric patients suffering from bacterial meningitis are shown in Table 3 .
Average Pharmacokinetic Parameters of Ceftriaxone in Humans Subject Group Elimination Half-Life (hr) Plasma Clearance (L/hr) Volume of Distribution (L) Healthy Subjects 5.8 - 8.7 0.58 - 1.45 5.8 - 13.5 Elderly Subjects (mean age, 70.5 yr) 8.9 0.83 10.7 Patients With Renal Impairment Hemodialysis Patients (0 - 5 mL/min)* 14.7 0.65 13.7 Severe (5 - 15 mL/min) 15.7 0.56 12.5 Moderate (16 - 30 mL/min) 11.4 0.72 11.8 Mild (31 - 60 mL/min) 12.4 0.70 13.3 Patients With Liver Disease 8.8 1.1 13.6 *Creatinine clearance.
Pharmacokinetics (US label) US FDA label
CLINICAL PHARMACOLOGY Average plasma concentrations of ceftriaxone following a single 30-minute intravenous (IV) infusion of a 0.5, 1 or 2 gm dose and intramuscular (IM) administration of a single 0.5 (250 mg/mL or 350 mg/mL concentrations) or 1 gm dose in healthy subjects are presented in Table 1. TABLE 1. Ceftriaxone Plasma Concentrations After Single Dose Administration Dose/Route Average Plasma Concentrations (mcg/mL) 0.5 hr 1 hr 2 hr 4 hr 6 hr 8 hr 12 hr 16 hr 24 hr 0.5 gm IV* 82 59 48 37 29 23 15 10 5 0.5 gm IM 250 mg/mL 22 33 38 35 30 26 16 ND 5 0.5 gm IM 350 mg/mL 20 32 38 34 31 24 16 ND 5 1 gm IV* 151 111 88 67 53 43 28 18 9 1 gm IM 40 68 76 68 56 44 29 ND ND 2 gm IV* 257 192 154 117 89 74 46 31 15 ND = Not determined. * IV doses were infused at a constant rate over 30 minutes.
Ceftriaxone was completely absorbed following IM administration with mean maximum plasma concentrations occurring between 2 and 3 hours post-dose. Multiple IV or IM doses ranging from 0.5 to 2 gm at 12 to 24 hour intervals resulted in 15% to 36% accumulation of ceftriaxone above single dose values. Ceftriaxone concentrations in urine are shown in Table 2.
TABLE 2. Urinary Concentrations of Ceftriaxone After Single Dose Administration Dose/Route Average Urinary Concentrations (mcg/mL) 0 - 2 hr 2 - 4 hr 4 - 8 hr 8 - 12 hr 12 - 24 hr 24 - 48 hr 0.5 gm IV 526 366 142 87 70 15 0.5 gm IM 115 425 308 127 96 28 1 gm IV 995 855 293 147 132 32 1 gm IM 504 628 418 237 ND ND 2 gm IV 2692 1976 757 274 198 40 ND = Not determined.
Thirty-three percent to 67% of a ceftriaxone dose was excreted in the urine as unchanged drug and the remainder was secreted in the bile and ultimately found in the feces as microbiologically inactive compounds. After a 1 gm IV dose, average concentrations of ceftriaxone, determined from 1 to 3 hours after dosing, were 581 mcg/mL in the gallbladder bile, 788 mcg/mL in the common duct bile, 898 mcg/mL in the cystic duct bile, 78.2 mcg/gm in the gallbladder wall and 62.1 mcg/mL in the concurrent plasma.
Over a 0.15 to 3 gm dose range in healthy adult subjects, the values of elimination half-life ranged from 5.8 to 8.7 hours; apparent volume of distribution from 5.78 to 13.5 L; plasma clearance from 0.58 to 1.45 L/hour; and renal clearance from 0.32 to 0.73 L/hour. Ceftriaxone is reversibly bound to human plasma proteins, and the binding decreased from a value of 95% bound at plasma concentrations of < 25 mcg/mL to a value of 85% bound at 300 mcg/mL.
Ceftriaxone crosses the blood placenta barrier. The average values of maximum plasma concentration, elimination half-life, plasma clearance and volume of distribution after a 50 mg/kg IV dose and after a 75 mg/kg IV dose in pediatric patients suffering from bacterial meningitis are shown in Table 3. Ceftriaxone penetrated the inflamed meninges of infants and pediatric patients; CSF concentrations after a 50 mg/kg IV dose and after a 75 mg/kg IV dose are also shown in Table 3.
TABLE 3. Average Pharmacokinetic Parameters of Ceftriaxone in Pediatric Patients With Meningitis 50 mg/kg IV 75 mg/kg IV Maximum Plasma Concentrations (mcg/mL) 216 275 Elimination Half-life (hr) 4.6 4.3 Plasma Clearance (mL/hr/kg) 49 60 Volume of Distribution (mL/kg) 338 373 CSF Concentration - inflamed meninges (mcg/mL) 5.6 6.4 Range (mcg/mL) 1.3 - 18.5 1.3 - 44 Time after dose (hr) 3.7 (± 1.6) 3.3 (± 1.4) Compared to that in healthy adult subjects, the pharmacokinetics of ceftriaxone were only minimally altered in elderly subjects and in patients with renal impairment or hepatic dysfunction (Table 4); therefore, dosage adjustments are not necessary for these patients with ceftriaxone dosages up to 2 gm per day.
Ceftriaxone was not removed to any significant extent from the plasma by hemodialysis; in six of 26 dialysis patients, the elimination rate of ceftriaxone was markedly reduced. TABLE 4. Average Pharmacokinetic Parameters of Ceftriaxone in Humans Subject Group Elimination Half-Life (hr) Plasma Clearance (L/hr) Volume of Distribution (L) Healthy Subjects 5.8 - 8.7 0.58 - 1.45 5.8 - 13.5 Elderly Subjects (mean age, 70.5 yr) 8.9 0.83 10.7 Patients With Renal Impairment Hemodialysis Patients (0 - 5 mL/min)* 14.7 0.65 13.7 Severe (5 - 15 mL/min) 15.7 0.56 12.5 Moderate (16 - 30 mL/min) 11.4 0.72 11.8 Mild (31 - 60 mL/min) 12.4 0.70 13.3 Patients With Liver Disease 8.8 1.1 13.6 *Creatinine clearance.
The elimination of ceftriaxone is not altered when ceftriaxone for injection is co-administered with probenecid. Pharmacokinetics in the Middle Ear Fluid In one study, total ceftriaxone concentrations (bound and unbound) were measured in middle ear fluid obtained during the insertion of tympanostomy tubes in 42 pediatric patients with otitis media.
Sampling times were from 1 to 50 hours after a single intramuscular injection of 50 mg/kg of ceftriaxone. Mean (± SD) ceftriaxone levels in the middle ear reached a peak of 35 (± 12) mcg/mL at 24 hours, and remained at 19 (± 7) mcg/mL at 48 hours. Based on middle ear fluid ceftriaxone concentrations in the 23 to 25 hour and the 46 to 50 hour sampling time intervals, a half-life of 25 hours was calculated.
Ceftriaxone is highly bound to plasma proteins. The extent of binding to proteins in the middle ear fluid is unknown. Interaction with Calcium Two in vitro studies, one using adult plasma and the other neonatal plasma from umbilical cord blood have been carried out to assess interaction of ceftriaxone and calcium. Ceftriaxone concentrations up to 1 mM (in excess of concentrations achieved in vivo following administration of 2 grams ceftriaxone infused over 30 minutes) were used in combination with calcium concentrations up to 12 mM (48 mg/dL).
Recovery of ceftriaxone from plasma was reduced with calcium concentrations of 6 mM (24 mg/dL) or higher in adult plasma or 4 mM (16 mg/dL) or higher in neonatal plasma. This may be reflective of ceftriaxone-calcium precipitation. Microbiology Mechanism of Action Ceftriaxone is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis.
Ceftriaxone has activity in the presence of some beta-lactamases, both penicillinases and cephalosporinases, of Gram-negative and Gram-positive bacteria. Mechanism of Resistance Resistance to ceftriaxone is primarily through hydrolysis by beta-lactamase, alteration of penicillin-binding proteins (PBPs), and decreased permeability.
Interaction with Other Antimicrobials In an in vitro study antagonistic effects have been observed with the combination of chloramphenicol and ceftriaxone. Ceftriaxone has been shown to be active against most isolates of the following bacteria, both in vitro and in clinical infections as described in the INDICATIONS AND USAGE section: Gram-negative bacteria Acinetobacter calcoaceticus Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzae Haemophilus parainfluenzae Klebsiella oxytoca Klebsiella pneumoniae Moraxella catarrhalis Morganella morganii Neisseria gonorrhoeae Neisseria meningitidis Proteus mirabilis Proteus vulgaris Pseudomonas aeruginosa Serratia marcescens Gram-positive bacteria Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus pyogenes Viridans group streptococci Anaerobic bacteria Bacteroides fragilis Clostridium species Peptostreptococcus species The following in vitro data are available, but their clinical significance is unknown.
At least 90 percent of the following microorganisms exhibit an in vitro minimum inhibitory concentration (MIC) less than or equal to the susceptible breakpoint for ceftriaxone. However, the efficacy of ceftriaxone in treating clinical infections due to these microorganisms has not been established in adequate and well-controlled clinical trials.
Gram-negative bacteria Citrobacter diversus Citrobacter freundii Providencia species (including Providencia rettgeri) Salmonella species (including Salmonella typhi) Shigella species Gram-positive bacteria Streptococcus agalactiae Anaerobic bacteria Porphyromonas (Bacteroides) melaninogenicus Prevotella (Bacteroides) bivius Susceptibility Test Methods For specific information regarding susceptibility test interpretive criteria and associated test methods and quality control standards recognized by FDA for this drug, please see: https://www.fda.gov/STIC.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Ceftriaxone 1 g + 10 mL diluent Vial | ₱13.78–₱180.00Reference ₱18.56 | per vial | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Ceftriaxone (as disodium/sodium salt) |
| PNF listing | Inj.: 250 mg vial + 2 mL 1% solution of lidocaine (IM) |
| PNF listing | Inj.: 500 mg vial + 2 mL 1% solution of lidocaine (IM) |
| PNF listing | Inj.: 250 mg vial + 5 mL diluent (IV) |
| PNF listing | Inj.: 1 g vial + 3.5 mL 1% solution of lidocaine (IM) |
| PNF listing | Inj.: 1 g vial + 10 mL diluent (IV) |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Ceftriaxone · Hikma Pharmaceuticals USA Inc. [US FDA-approved label, version 18, September 30, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8351aa37-552d-471d-b293-c564dcb6ec29
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
- Hikma Pharmaceuticals USA Inc. (2026). Ceftriaxone for injection, USP [Prescribing information; US FDA-approved label, ANDA065342, set ID 8351aa37-552d-471d-b293-c564dcb6ec29, version effective September 30, 2026]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8351aa37-552d-471d-b293-c564dcb6ec29
- Li, L., Li, X., Xia, Y., Chu, Y., Zhong, H., Li, J., Liang, P., Bu, Y., Zhao, R., Liao, Y., Yang, P., Lu, X., & Jiang, S. (2020). Recommendation of antimicrobial dosing optimization during continuous renal replacement therapy. Frontiers in Pharmacology, 11, Article 786. https://doi.org/10.3389/fphar.2020.00786
- Li, P. K.-T., Chow, K. M., Cho, Y., Fan, S., Figueiredo, A. E., Harris, T., Kanjanabuch, T., Kim, Y.-L., Madero, M., Malyszko, J., Mehrotra, R., Okpechi, I. G., Perl, J., Piraino, B., Runnegar, N., Teitelbaum, I., Wong, J. K.-W., Yu, X., & Johnson, D. W. (2022). ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Peritoneal Dialysis International, 42(2), 110–153. https://doi.org/10.1177/08968608221080586
renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.
Last updated: .

